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Abstract 
Epidemiological studies have linked small birth weight and rapid compensatory growth 
to a number of chronic diseases, such as type 2 diabetes, hypertension and cardiovascular 
disease (Chapter 1). Despite their many uses in biomedical research, few studies have 
used swine as a model for fetal programming. The overall goal of this research was to 
develop a Yucatan miniature pig model of fetal programming. Specifically we wanted to 
determine the effects of birth weight, postnatal growth rate and early postnatal nutrition 
on the development of type 2 diabetes in Yucatan miniature swine (Chapter 2). In order 
to do so, we needed to demonstrate compensatory growth (Chapter 3) and validate the 
miniature pig as a model for type 2 diabetes (Chapter 4). Although runt pigs displayed 
compensatory growth, growth characteristics were not related to any markers of type 2 
di~betes development (Chapter 5). 
Key Words: Yucatan, miniature pig, compensatory growth, type 2 diabetes, fetal 
programmmg 
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Chapter 1 Literature Review 
1.1 Fetal Programming 
The Barker Hypothesis 
Epidemiological studies have linked low birth weight and high postnatal growth 
rate to a number of chronic diseases, including type 2 diabetes, hypertension, obesity, and 
cardiovascular disease (McMillen and Robinson, 2005). Dr. David Barker of 
Southampton University, UK first described this relationship between low birth weight 
and later adult disease as fetal programming in the early 1990s. Fetal programming is 
defined as the long-term consequences of a nutritional insult experienced in early life. 
The nutritional insult can be anything from insufficient total nutrients to a specific 
nutrient deprivation. The nutritional insult permanently re-programs the animal's 
metabolism in such a way that the animal becomes more susceptible to the development 
of chronic diseases. The actual mechanism of this re-programming is unknown. 
The Thrifty Phenotype Hypothesis 
Hales and Barker described the thrifty phenotype hypothesis in 1992. They 
proposed that the nutritional environment sensed by the fetus in utero causes changes in 
fetal metabolism. For example, in response to nutrient shortages in utero, the fetus 
switches to a conservation metabolism that biologically prepares it for nutrient shortages 
after birth. The fetus redistributes nutrients to promote the growth of the brain at the 
expense of other organ systems such as the liver, pancreas and kidneys. This 
redistribution, termed organ sparing, has profound irreversible effects on cell number and 
organ size (Kind et al2003, Ritacco et al1997). The consequences ofthis fetal 
adaptation are dependent upon postnatal nutrition. In Westernized countries where 
infants are provided with excessive nutrients, the prenatal switch to conservation 
metabolism and organ sparing creates a situation where the large metabolic demand of 
excessive nutrients cannot be handled by the limited cell number. As a result, the infant 
experiences appetite dysregulation, obesity, and insulin resistance. However, when low 
birth weight animals receive poor postnatal nutrition from undernourished mothers, the 
risk of later obesity decreases. It is the mismatch of prenatal and postnatal environments, 
which leads to later problems. 
Defining Birth Weight 
Another interesting observation is that the risk of chronic disease development 
decreases with increasing birth weights (McMillen and Robinson, 2005). The 
observation leads to the question, how does one define low birth weight? Low birth 
weight in humans is usually defined as an infant born at term weighing less than 2500 g 
(Dewey, 1998, Rasmussen, 2001). These infants are considered small for their 
gestational age compared to normal or large birth weight infants in a reference 
population. There are many factors that influence birth weight including maternal 
nutrition, smoking, placental disease, birth order, multiple births and genetics. Regardless 
of what factors contributed to birth size, the absolute birth weight of an infant does not 
necessarily reflect its intrauterine environment. For example, a lower birth weight infant 
may have reached its genetic potential for size. This infant would not have experienced 
any perturbations in growth during gestation to account for its small size at birth. The 
opposite is true in that normal birth weight babies could have been born larger, but 
instead were growth-restricted during gestation and unable to reach their genetic potential 
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for size. It is difficult to determine whether a human infant has reached its genetic 
potential for size at birth. 
It is important to note that the majority of epidemiological studies investigating 
fetal programming do not include clinical low birth weight infants of <2500 g. Instead, 
these studies examine infants across a range of normal weights (2500- 4000 g) (Dewey, 
1998, Rasmussen, 2001 ). Although adult disease risk decreases over an increasing range 
of normal birth weights; it is not possible to determine which infants had undergone any 
disruptions in intrauterine growth. Therefore, researchers have looked to early postnatal 
growth as an indicator of the conditions of the intrauterine environment. 
Animal Models of Fetal Programming 
Although extensive epidemiological evidence has demonstrated an association 
between low birth weight and later adult disease, what causes this association is 
unknown. In order to better understand fetal programming several animal models of low 
birth weight have been developed. The rat, mouse, guinea pig, sheep and domestic pig 
have all been used as models for examining the fetal origins of adult disease. There are 
several different approaches to controlling the nutrient supply to the fetus to induce low 
birth weight animals including surgical methods, global under nutrition and protein 
deprivation. 
Surgical Methods 
In rodents, intrauterine artery ligation has been used to limit blood flow to the 
fetus. The result is impaired fetal development and severely reduced birth weight. 
Jansson and Lambert ( 1999) ligated the uterine artery of one hom on day 12 of gestation 
and rat dams delivered very low birth weight pups spontaneously on day 22. 
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Radiotelemeters were installed in the offspring at 3 months of age and these animals also 
underwent an intravenous glucose tolerance test. Although there were no differences in 
blood pressure between animals of very low birth weight and controls, females had 
significantly higher fasting blood glucose and lower fasting plasma insulin. A similar 
surgical method has been performed with sheep. The endometrial caruncles are removed 
(carunclectomy) restricting blood flow to the fetus producing lambs born half the normal 
- ---size('Bertram and Hanson, 2001). Although low birth weight is achieved in this surgical 
model, it is excessive and there is increased prenatal mortality. Placental disease in 
humans can decrease blood flow to the fetus resulting in very low birth weight. 
Global Under Nutrition 
Restriction of total nutrients, often termed global under nutrition, involves 
restricting the maternal diet to 30-90% of caloric requirement during gestation. Severe 
nutrient restriction is considered 30-50% of energy requirement, moderate restriction 50-
70% and mild ranging from 80-90% of energy requirement (Bertram and Hanson 200 I, 
Kind et al 2003). Maternal feed restriction limits the supply of nutrients to the fetus. The 
result is slowed fetal growth and development causing low birth weight animals. When 
rat dams were fed 50% of ad libitum during the second half of gestation, they gave birth 
to very low birth weight pups (Bertin et al 1999). At 80 days of age, female rats born to 
feed-restricted mothers had significantly higher glucose, lower insulin and impaired 
vascular function compared to control rats. Kind and colleagues (2003) found similar 
results in guinea pigs. The offspring of mild (85% ad libitum) and moderate (70% ad 
libitum) maternal feed restriction had significantly lowered birth weight compared to 
offspring of mothers fed ad libitum during gestation. Male offspring of mothers who 
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suffered moderate feed restriction had significantly higher fasting insulin and ratio of 
fasting insulin to glucose compared to mild restriction and control animals at 90 days of 
age. Offspring of mothers fed 50-70% of energy requirement did not experience any 
symptoms of chronic disease (Kind et al., 2001 ), suggesting that feeding mothers 30-50% 
of their requirement may be necessary to observe risk factors of disease in the offspring. 
' Global under nutrition models are reflective of humans that have experienced a period of 
famine or people living in underdeveloped countries. However, the majority of 
epidemiological studies examining fetal programming are performed in developed 
countries where famine situations are less frequent. 
Low Protein 
The most extensively used model for studying fetal programming is the low 
protein rat model. Since fetal growth is largely dependent upon protein supply, 
researchers have restricted maternal dietary protein by up to 50%. There are two main 
low protein diets used by researchers to induce low birth weight, the Southampton and 
Hope Farm diets. Langley-Evans performed a study that directly compared the two diets 
(2000). They found that rats whose mothers were fed the low protein Southampton diet 
had significantly higher systolic blood pressure at 4 weeks than rats whose mothers were 
fed low protein Hope Farm diet and than offspring of mothers fed adequate protein during 
gestation. These findings suggest that protein content per se may not lead to fetal 
programming. Because the fatty acid composition, total fat and methionine content, of 
the maternal diet were different any of these other nutrients can contribute to fetal 
programming. Although maternal protein restriction induces low birth weight, the model 
does not focus on the effects of low birth weight on the development of later disease, 
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rather the model focuses on how alterations of maternal nutrition during gestation leads to 
chronic disease development. The majority of epidemiological studies of fetal 
programming specifically link low birth weight to later chronic disease, and do not focus 
on maternal nutrition during gestation. 
Metabolic Mechanisms 
Through the use of animal models, several hypotheses to explain metabolic 
mechanisms of fetal programming have been proposed. One theory is that excessive 
exposure to maternal glucocorticoids in utero causes permanent changes in the 
hypothalamo-pituitary-adrenal (HPA) axis that lowers birth weight and programs adult 
hypertension and glucose intolerance (Nyirenda et al., 1998). Another recent hypothesis 
is that maternal nutritional status can cause epigenetic changes in the fetal genome 
leading to altered DNA methylation (Wu et al., 2004). Abnormal DNA methylation 
during fetal development can permanently alter fetal metabolism in such a way that the 
individual becomes more likely to develop chronic disease later in life. Although the 
metabolic mechanisms are not yet elucidated, animal models of fetal programming have 
proved to be invaluable to advance the understanding of fetal programming and its 
mechanisms. 
1.2 Compensatory Growth 
The majority of low birth weight infants will undergo a period of accelerated 
postnatal growth, termed compensatory or catch-up growth. During this period, nutrient 
efficiency is increased allowing for rapid growth. However, this increased efficiency 
does not last and once over, growth continues according to age and size (Metcalfe and 
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Monaghan, 2001 ). The period of compensatory growth usually occurs during the first 6-9 
months of life, while milk is the dominant food source (Rasmussen, 2001). It is important 
to note that low birth weight does not cause compensatory growth. Catch-up growth 
occurs as a result of periods of nutritional insult or illness; therefore, infants within the 
normal range of birth weights can also experience compensatory growth. In fact, roughly 
30% of infants experience catch-up growth (McMillen and Robinson, 2005). Moreover, 
-·----Infants. born large for their gestational age undergo catch-down growth during the first 6-9 
months of life (Rasmussen, 2001 ). There is epidemiological evidence suggesting that 
small birth weight infants that experience catch-up growth are at even higher risk for the 
development of chronic diseases (McMillen and Robinson, 2005). 
Mechanisms of Compensatory Growth 
The mechanism of catch-up growth is not well understood. One proposal is that 
the central nervous centre compares the actual body size to an age-appropriate size and 
adjusts growth accordingly (Gafni and Baron, 2000). Another theory is that 
compensatory growth involves the proliferation of growth plate stem cells (Gafni and 
Baron, 2000). Despite the fact that little is understood about the underlying mechanisms. 
most animals exhibit compensatory growth including fish, reptiles, amphibians, birds, 
rats, pigs and humans (Metcalfe and Monaghan, 2001 ). Compensatory growth increases 
short-term survival of most animals, allowing them to reach sexual maturity more 
quickly. The long-term consequences are poorly understood and have received little 
attention in most species. However, in some studies, life expectancy is compromised as a 
cost of this catch-up growth in some species such as salmon, zebra fish and rats (Metcal fc 
and Monaghan, 2001 ). Rats subjected to protein restriction in utero have reduced cell 
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numbers in key organs that can not keep up with the increased metabolic demand during 
compensatory growth (Hales and Barker, 2001). As a result, the rat is more likely to 
develop chronic diseases that can decrease life expectancy. The fetal programming 
hypothesis has brought back a resurgence of interest in understanding the metabolic 
consequences of compensatory growth. Large epidemiological studies in the United 
Kingdom and Finland have extensively studied the growth patterns of these populations. 
Epidemiological Evidence Linking Catch-Up Growth to Later Disease 
The short-term effects of catch-up growth have been studied extensively in 
developed nations. Body weight and length records at birth, 2 years and 5 years of age 
were collected from infants enrolled in the United Kingdom's Avon Longitudinal Study 
of Pregnancy and Childhood (ALSPAC) in order to examine postnatal growth (Ong et al., 
2000). Infants, who experienced catch-up growth during this period, were smaller, 
shorter and thinner at birth compared to all other infants. When examined at 5 years of 
age, those infants who experienced compensatory growth had higher body mass indices 
(BMI), percentage body fat, total fat mass and waist circumference compared to all other 
infants. Infants who caught up in length from birth to 2 years had higher BMI and fat 
mass at 5 years of age than all other infants. These findings demonstrate that 
compensatory growth in body weight and length of low birth weight infants has profound 
effects on weight gain and fat deposition at five years of age. Further studies have 
investigated whether this trend persists into adulthood and its consequences on adult 
health. 
A series of retrospective studies was performed using data from the Helsinki 
Finland cohort, which related birth weight, and growth rates between the ages of 7-15 to 
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coronary heart disease and type 2 diabetes in adulthood (Forsen et al., 1999 and 2000, 
Eriksson et al., 1999). In relation to birth weight, the odds ratio for type 2 diabetes was 
1.38 for each 1 kg decrease in birth weight. These results show that the odds for type 2 
diabetes development increase along a range of decreasing birth weights, suggesting a 
graded response. Perhaps most interesting, this study also found a strong relationship 
between growth rate between 7- 15 years and later type 2 diabetes development (Forsen 
et al., 2000). The findings of this study suggest a relationship between birth weight and 
postnatal growth rate and later development of type 2 diabetes. 
Challenges/Problems with Human Studies 
Although postnatal growth rate can be linked to the development of chronic 
diseases, there are many factors that affect postnatal growth rate. When examining 
epidemiological studies, it is important to consider the mode of feeding during the first 
year of life. According to World Health Organization growth records, breast fed babies 
grow faster during the first 2 months and slower from 3-12 months than formula fed 
infants (Dewey, 1998). Dewey (1998) performed a meta-analysis of 19 studies from 
1980-92 comparing growth ofbreast-fed and formula fed infants in the same population. 
Overall, formula fed infants gained more weight in the first year of life compared to 
breast fed infants. However, there are several limitations and confounding factors that 
impact studies of this nature. For example, each milk formula composition varies 
slightly. Also, it is impractical to quantify breast milk intake during this period. Maternal 
smoking, disease and nutrient intake during pregnancy will all affect the infant's postnatal 
growth and must be considered when drawing epidemiological conclusions. Using 
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animals to study compensatory growth is advantageous, as it is easier to control for the 
confounding factors plaguing human studies 
Animal Models of Compensatory Growth 
As mentioned previously, the low protein rat model is commonly used for 
inducing low birth weight pups. Restricting maternal protein during lactation provides a 
unique model for examining the impact of early infant nutrition on postnatal growth. In a 
recent study by Desai and colleagues (2005), pups of protein-restricted dams that were 
left on a dam restricted during lactation, remained small throughout life. However, when 
cross-fostered onto a control dam, pups grew significantly faster and were larger than 
control pups by 3 weeks of age and remained larger at 9 months of age (Desai et al., 
2005). At 9 months of age, these rats had a significantly lower percent lean body mass 
and higher percent fat mass compared to control animals indicating obesity. 
Despite their many uses in medical research, few studies have examined 
compensatory growth in pigs in relation to fetal programming of later diseases. However, 
research on compensatory growth in pigs has been widely studied by agricultural 
scientists. Ritacco and colleagues ( 1997) compared postnatal growth characteristics of 
runt piglets to larger same sex littermates from birth until 14 days of age. Runt piglets 
experienced a faster relative rate of growth than their littermates. Also, the feed 
efficiency (g feed: g gain) was significantly better (i.e. lower) in runts than larger 
littermates. Poore and Fowden (20043 ) also found that the relative rate of growth was 
significantly higher in runt piglets from 3 -12 months of age compared to larger 
littermates. In terms of absolute body weight, runts were significantly smaller at 3 
months of age than littermates, but not at 12 months of age. These runt pigs were found 
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to have impaired glucose tolerance at 12 months of age. Although, there is limited 
research on pigs and fetal programming, they do demonstrate compensatory growth that 
contributed to later disease. 
1.3. Diabetes and Fetal Programming 
The prevalence of hypertension, cardiovascular disease, obesity and type 2 
diabetes in Westernized countries is increasing rapidly (Rader, 2007). Type 2 diabetes 
has become an epidemic in North America. The explosive rise in the incidence of type 2 
diabetes is paralleled with an equally explosive increase of obesity. This observation is 
not surprising as obesity, especially visceral obesity, is strongly related to type 2 diabetes 
(Rader, 2007). What is alarming is the extremely high incidence of childhood and 
adolescent obesity and type 2 diabetes. Studies in Spain, India and France have shown 
insulin resistance in children as young as 8 years of age (Bavdekar et al., 1999, Ibanez et 
al., 2003, Leger et al., 1997). Insulin resistance refers to the impaired uptake of glucose 
by muscle and typically precedes both obesity and diabetes. Insulin resistance is 
characterized by high fasting plasma insulin needed to keep the individual in euglycemia. 
However, the pancreas cannot keep up with the insulin demand. Hyperglycemia results 
and the individual becomes type 2 diabetic. It is now thought that low birth weight and 
obesity in childhood is a stronger predictor of insulin resistance than ofbeing obese as an 
adult (Hales and Barker, 2001). 
In the ALSP AC prospective cohort study of children born in the United Kingdom, 
detailed growth records were obtained from birth and compensatory growth was defined 
as children that had upwardly crossed a centile from 0-3 years of age. In a recent study 
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by Ong and colleagues (2004) using this cohort, children that experienced catch-up 
growth had higher BMI, waist circumferences and lower insulin sensitivity at 8 years of 
age. In children with the highest BMI, low birth weight was strongly associated with 
insulin resistance. Cohorts of children in India and North America have demonstrated 
similar results (Dunger and Ong, 2005). 
Although the data regarding childhood insulin resistance are relatively recent, 
there is extensive epidemiological evidence demonstrating a relationship between low 
birth weight and postnatal growth on the development of type 2 diabetes in adults. 
Poulsen and colleagues (1997) studied the effects of birth weight on the development of 
type 2 diabetes in monozygotic and dizygotic twins. Twins aged 55-74 were selected 
from the Danish Twin Register. Twins that participated in the study underwent an oral 
glucose tolerance test and fasting glucose, insulin, triglycerides and cholesterol were also 
determined. Individuals of the lowest birth weight had significantly higher 120 minute 
plasma glucose and glucose area under the curve during the oral glucose tolerance test. 
When twins were paired, twins that were diagnosed with type 2 diabetes were born at 
significantly lower birth weight than their non-diabetic co-twins. This finding suggests 
that birth weight is a strong predictor of later type 2 diabetes development, as factors such 
as genetics, gestational age, maternal height/weight and birth order were similar in twins. 
Timing of Nutrient Restriction 
Despite the substantial epidemiological evidence linking birth weight and 
postnatal growth to childhood insulin resistance and adult type 2 diabetes, rat studies have 
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failed to duplicate these findings. Rats whose mothers were protein-restricted during 
gestation have better glucose tolerance at weaning than rats that were not restricted in 
utero (Shepherd et al., 1997). However, later in life, the low protein rats have much 
worse glucose tolerance than control animals. These results only occurred if the rat 
protein-deprived in utero is suckled from a well-nourished dam. In order to better 
understand these findings, researchers looked into the effects of protein deprivation on 
specific organ systems involved in glucose homeostasis, specifically the pancreas. 
Pancreatic beta cell number is greatly decreased in protein-deprived pups at birth 
(Bertram and Hanson, 2001 ). A reduced beta cell number should decrease the insulin 
production and secretion capacity compared to non-restricted animals. However, in rats 
cross-fostered onto a well-nourished mother during lactation, the beta cell mass is 
restored, whereas, in those left with a dam protein-deprived during lactation, the 
restoration of beta cell number does not occur. One explanation for this oddity is that rats 
are altricial species, meaning they experience extensive maturation postnatally. 
Pancreatic islet cell neogenesis occurs in two periods in rats (Hill and Duvillie, 2000). 
Pancreatic islets are present during late gestation but are not responsive to glucose, only 
to amino acids (Hill and Duvillie, 2000). Shortly after birth in rats, the islet cells already 
present are replaced with new islet cells that are responsive to glucose and able to secrete 
insulin. It has been suggested that this new population of islet cells will have metabolic 
control in later life. Therefore, any perturbations to islet cell development in utero have 
the potential to be corrected postnatally if the second population of islet cells is unaltered 
(Hill and Duvillie, 2000). Humans, however, are precocial meaning they are born with 
highly developed cardiovascular and endocrine systems at birth. Unlike the rat, human 
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pancreatic islet cells are mature and develop glucose responsiveness during the third 
trimester of pregnancy (Hill and Duvillie, 2000). Therefore, any disruption to pancreatic 
development during late gestation can lead to altered metabolism in later life. 
Since pancreatic organogenesis occurs during the third trimester of human 
pregnancy, it is not surprising that maternal food restriction during this time would lead to 
type 2 diabetes later in life. Unique human data were generated on the effects of nutrient 
restriction in utero during the Dutch winter famine. During the Second World War, food 
was restricted to the western Netherlands from November 1944 until May 1945. Caloric 
intakes ranged from 400-1000 kcal/d. Many researchers have studied adults that were in 
utero during the famine for signs of fetal programming. Adults that were nutrient-
restricted in utero during the first trimester of pregnancy had high rates of cardiovascular 
disease. Those restricted in late gestation experienced insulin resistance, type 2 diabetes 
and hypertension in adulthood (Barker et al. 1993). Ravelli and colleagues (1998) found 
that individuals subjected to the famine in utero during mid to late gestation had 
significantly higher 2-hour glucose levels during an oral glucose tolerance test than those 
affected during the first trimester. Individuals subjected to famine during late gestation 
displayed a greater degree of glucose intolerance than those restricted during mid 
gestation. These results confirm that the timing of nutrient restriction in utero influences 
which diseases are programmed. More animal models are needed to fully understand the 
impact of maternal nutrient restriction during specific periods of gestation on 
organogenesis of the pancreas and later disease development. Specifically, precocial 
animals such as the pig would make an excellent model of study. 
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The pig has been used extensively as a model for studying many aspects of both 
insulin dependent and non-insulin dependent diabetes including pancreatic beta cell 
function and mass. The pig shares very close nutritional, physiological and metabolic 
similarities with humans making it an ideal model of study. However, few researchers 
have used the pig as a model for studying the fetal programming of type 2 diabetes. 
Recently, Poore and Fowden (2002, 2003, 2004a, 2004b) published several articles 
introducing the domestic pig as a model for fetal programming. They studied low and 
high birth weight pigs at 3 and 12 months of age for the development of hypertension, 
cardiovascular disease, obesity and type 2 diabetes. Growth characteristics including 
body weight, body length and crown rump length were taken at birth, 1, 3 and 12 months. 
Fractional growth rates (kg gained/dlkg BW) from 0-1 months, 0-3 months, 3-12 months 
and 0-12 months were determined. Low birth weight pigs had a faster fractional growth 
rate than high birth weight animals from 0-1 months of age, which was considered 
compensatory growth. At 3 and 12 months of age pigs were surgically fitted with venous 
catheters and intravenous glucose tolerance tests and insulin sensitivity tests were 
performed. There was no evidence of disease development in the pigs at 3 months of age, 
but at 12 months of age, the glucose and insulin areas under the curve were significantly 
higher in low birth weight pigs than high birth weight pigs. Low birth weight pigs also 
had significantly lower fasting plasma insulin at 12 months. Furthermore, the glucose 
area under the curve at 12 months was negatively associated with birth weight. These 
findings support the use of domestic pigs as a model for studying fetal programming, 
however, more pig studies are needed to validate the model. 
Animal Models of Fetal Programming and Insulin Resistance 
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The main animals used to study fetal programming are the sheep and rat. 
Although both species have proven to be effective models of study, each has its 
drawbacks. The sheep is a well-established model for fetal human physiology. It is easy 
to catheterize fetal sheep and study the intrauterine environment. Therefore, the 
metabolic mechanisms of fetal programming can be determined. However, long-term 
studies of the consequences of a poor intrauterine environment are rarely performed 
because the sheep is a ruminant animal. Ruminants have completely different nutrient 
requirements, feeding behaviours and digestive physiology than humans. The rat is the 
most extensively used animal for studying fetal programming. Rats are small, easy to 
handle, maintain and house, and are a widely accepted model for studying many facets of 
human metabolism and physiology. Rodents are also short-lived and can be forced to 
develop chronic diseases in aging similar in etiology to humans. However, the rat has 
very different nutrient requirements and feeding behaviours than humans. Also, rats are 
altricial, experiencing extensive maturation postnatally during suckling, whereas, humans 
are precocial, meaning they have a highly developed central nervous system, 
cardiovascular and endocrine system at birth. Very recently the domestic pig was used as 
a model for fetal programming. Like rats, pigs are litter-bearing animals, which enables 
direct comparisons of runts to genetically similar larger littermates. Pigs demonstrate 
compensatory growth (Ritacco et al. 1997, Wolter et al. 2002, Poore and Fowden 2004a) 
and are physiologically and nutritionally very similar to humans. Moreover, the pig has 
been used successfully as a model for many chronic diseases such as diabetes, 
cardiovascular disease, hypertension, and obesity (Kjems et al. 200 I, Larsen et al. 2002, 
Poore and Fowden 2002, Otis et al. 2003, Xi et al. 2004, Sebert et al. 2005). 
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1.4 Swine Models 
Although domestic swine are physiologically very similar to humans, they do 
have some disadvantages. As a livestock animal, the pig has been genetically selected for 
rapid growth rates and protein deposition. Therefore, they are less prone to develop 
obesity. Other breeds of pigs, such as the miniature pig, would make an even better 
model for fetal programming than the domestic pig. Yucatan miniature pigs are smaller 
in size than domestic pigs, reaching an adult size of roughly 70 kg. Bred solely for 
research purposes, the miniature pig grows slowly and has been shown to develop obesity 
and type 2 diabetes (Larsen et al. 2002, Otis et al. 2003, Sebert et al. 2005). However, no 
researchers have used the miniature pig as a model for studying the early origins of adult 
disease. 
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Chapter 2: Objectives 
The primary goal of this research was to develop a miniature pig model for 
studying fetal programming. Our specific objectives were as follows: 
1. Establish the Yucatan miniature pig as a model for compensatory growth. 
2. Validate the use of the Yucatan miniature pig as a model for type 2 diabetes. 
3. Determine the effects of birth weight and postnatal growth rate on the 
----------- -- -development oftype 2 diabetes. (This model was also used to investigate other 
chronic diseases including hypertension, obesity, and cardiovascular disease but 
those results are not part of this thesis). 
4. Determine the impact of early postnatal nutrition (i.e. sow fed vs. formula fed) on 
the susceptibility to type 2 diabetes. 
We hypothesize that low birth weight runt pigs will undergo compensatory growth 
and develop signs of type 2 diabetes more readily than their larger birth weight 
littermates. We also hypothesize that suckled piglets will have fewer indicators of disease 
than either formula fed runts or large littermates. 
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Chapter 3 Compensatory Growth 
3.1 Introduction 
Low birth weight infants typically undergo a period of accelerated postnatal 
growth, tem1ed compensatory or catch-up growth. Epidemiological evidence has shown 
that low birth weight infants that experience compensatory growth are at an even higher 
risk for the development of chronic diseases than infants born of low birth weight alone. 
This recent evidence has stimulated a resurgence of interest in understanding the 
mechanisms of compensatory growth, which still remain unclear. The purpose of the 
experiments discussed in this chapter was to validate the Yucatan miniature pig as a 
model for compensatory growth. 
3.2 Methods 
Animals and housing 
A total of 18 Yucatan miniature pigs were obtained from the Memorial University 
of Newfoundland Vivarium, where they were housed until 8 months of age. One day 
after a sow gave birth, the entire litter was weighed. A runt piglet was defined as 
weighing less than 900 grams. A same sex larger littermate weighing at least 300 grams 
more than the runt was chosen as a littermate control. A third littermate (sow-fed control) 
was selected at this time and left with the sow until weaning. We attempted for the sow-
fed control to be the next largest same sex littermate, however, it was not possible in all 
litters. Therefore, in two of the triplets the sow-fed control is a different sex from the runt 
and littermate. Overall there was an equal number of males and females used in this 
study. The runt and larger littermate were taken from the sow at 3 days of age, allowing 
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for adequate colostrum intake. Piglets were housed together and provided with straw 
bedding and an infrared heat lamp. Milk replacer (Piglet-Oro, Grober Nutrition, 
Cambridge Ontario) was rehydrated and was bowl-fed ad libitum eight to ten times daily. 
Individual milk intake was measured and recorded after each feeding. At one month of 
age, piglets were adapted to standard pig chow (Eastern Co-op Pig Grower, 16% crude 
protein) over a 3-day period. At this time, the third (sow-fed) control piglet was 
introduced and also adapted to chow. Pigs were then housed in triplets, but fed separately 
for 5 hours daily from 12- 5pm ad libitum. Feed intake was measured daily and animals 
had free access to water. The Institutional Animal Care Committee in accordance with 
the Canadian Council of Animal Care guidelines approved this study. 
Procedures 
Serial growth measurements were taken from birth to 8 months of age. During the 
milk feeding phase, body weight, snout to tail length, and abdominal circumference were 
measured 1-2 times weekly. After adaptation to chow, these measurements were made 1-
2 times a month. The largest part of the abdomen was measured as the abdominal 
circumference (em). Ten millilitre blood samples in EDTA tubes were taken via jugular 
venipuncture from one month until 3 months of age 1-2 times monthly; pigs were 
restrained in a V -trough. From 3 months until eight months of age, 20 ml blood samples 
in EDT A tubes were collected 1-2 times per month. Blood samples were centrifuged for 
1 0 minutes at 4000 x g at 4 °C. The plasma was obtained and stored at -20 °C for later 
analysis. At roughly 8 months of age pigs were transported to the Health Sciences Center 
(HSC), Memorial University of Newfoundland where they remained for the remainder of 
the study. Shortly after arrival at the HSC, two catheters were implanted into the femoral 
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vein and a radiotelemeter into the femoral artery. Details of the surgical procedure will 
be discussed in the following chapter. Four weeks after surgery pigs were killed. 
Statistical Analysis 
All statistical analyses were performed using Graph Pad Prism 4 software. The 
analysis was divided into milk feeding phase (ages 3-31 d) and chow feeding phase (1-8 
months). Linear regression was used to determine growth rates during both phases and 
--------- - - · --------sfopeswere compared. During the milk feeding phase, comparisons between runt, 
littermate and sow-fed were made by repeated measures 1-way ANOVA, with repeated 
measures analysis used to assess blocking by litter. Because two of the sow-fed piglets 
were gender mismatched to their littermates, we could not compare gender effect and 
litter blocking effect simultaneously (2-way ANOVA repeated measures). So to 
accommodate gender matching in formula-fed piglets, paired students t tests were also 
used to make runt and littermate comparisons. During the chow feeding phase, we 
expected gender blocking to have a larger effect than litter matching on growth 
parameters; so during this phase, differences between groups and gender were determined 
using non-repeated measures 2 way ANOV As. In analyses where gender had no effect 
we presented the data as group means. When gender had an effect, the data was 
represented as figures. In all analyses, statistical significance was declared ifp < 0.05. 
All data are expressed as mean, plus or minus standard deviation. 
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3.3 Results 
Growth characteristics at birth 
The average litter size was 7.0 ± 1.0 with the mean weight being 0.896 ± 0.084 
kg. The body measurements of piglets one day after birth are found in Table 3 .1. Runt 
piglets were significantly smaller in weight, length and abdominal circumference than 
their larger littermate and sow-fed control one day after birth. There were no significant 
differences in size between littermate and sow-fed controls. 
Table 3.1: Body weight (kg) and linear growth and abdominal circumference (em) (body 
length and abdominal circumference, em) one day after birth in runt, littermate and sow-
fed control piglets. 
Runt Littermate Sow-fed Control 
Body weight (kg) 0.730 ± 0.106 a 1.1097 ± 0.1337 ° 1.0149 ± 0.1609 ° 
Body length (em) 31.7±2.7 a 35.5 ± 1.5 ° 35.6 ± 2.1 ° 
Abdominal 23.1 ± 1.6 a 27.6 ± 1.1 b 27.4 ± 0.5 b 
circumference (em) 
a p< 0.001 (ANOVA) 
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Growth characteristics during the milk feeding phase (3 days-1 month of age) 
Feed intake 
Milk intake was measured in runts and littermates only, as it was not possible to 
quantify sow-fed control sow milk intake while with their mothers. Large littermates 
consumed more milk replacer than runts on a daily basis (Figure 3.1). 
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Figure 3.1: Average daily milk replacer intake (ml/d) of 
runt and littermate pigs during milk feeding. 
• Runt 
a Littermate 
-Line of regression of Runt (r2=0.80) 
---·Line of regression ofLittermate (r2=0.66) 
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Feed efficiency was calculated as the kilograms of feed required to produce one 
kilogram of gain. The overall average feed efficiency for the month of milk feeding was 
not different between runts and littermates. Therefore, weekly averages were determined 
to look for changes in feed efficiency over time (Table 3.2). The most efficient growth 
was experienced during the first week of milk feeding, and declined over time. During 
the second week of formula feeding only, runt piglets had significantly better feed 
efficiency than their littermates (p=0.03). This short period of increased nutrient 
efficiency is characteristic of compensatory growth. 
Table 3.2: Average feed efficiency (kg feed: kg gain) from day 3-31,3-10, 11-17, 18-24 
and 25-31 in runt and littermate piglets. 
Runt Littermate 
Average feed efficiency (Day 3-31) 1.3 ± 0.2 1.3 ± 0.1 
Feed efficiency (Day 3-10) 0.7± 0.2 0.8± 0.2 
Feed efficiency (Day 11-17) 1.0 ± 0.1 a 1.3 ± 0.2 D 
Feed efficiency (Day 18-24) 1.2 ± 0.1 1.2 ± 0.2 
Feed efficiency (Day 25-31) 1.7±0.3 1.8 ± 0.2 
a p=0.03 
Growth rates during milk feeding 
During the milk-feeding phase, the growth rates of all piglets were linear (Table 
3.3). Runt piglets grew at a significantly slower rate than other pigs (p=0.008) (Figure 
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3.2, table 3.3). Large littermates grew at the same rate as sow-fed controls. Body length 
and abdominal circumference also increased linearly during milk feeding (Table 3.3). 
The rate of length gain and rate of abdominal gain was not significantly different between 
pigs. 
Table 3.3: Growth rates (body weight, kg/d, body length and abdominal circumference, 
em/d) of runt, littermate and sow-fed control piglets during milk feeding (1st month of 
life) 
Growth Rates Runt Littermate Sow-fed 
Body weight (kg/d) 0.1389 ± 0.0060 a 0.1668 ± 0.0087 ° 0.1780 ± 0.0118 ° 
r2=0.93 r2=0.89 r2=0.85 
Body length (em/d) 0.74 ± 0.05 0.82 ± 0.03 0.76 ± 0.05 
r2=0.83 r=o.93 r2=0.88 
Abdominal circumference 0.71 ± 0.03 0.69 ± 0.03 0.63 ± 0.06 
(em/d) r2=0.92 r=o.9o r2=0.81 
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Figure 3.2: Lines of regression of runt, littermate and sow-fed 
control pigs for growth rate (kg! d) during milk feeding 
o Runt -Runt r2=0.93 
a Littermate --· Littermate r2=0.89 
• Sow-fed ---·Sow-fed r2=0.85 
Runt and sow-fed piglets grew at a similar rate as a percentage of their initial body 
weight. Large littermates grew significantly slower as a percentage of their initial weight 
compared to runt and sow-fed controls (p=O.OOl) (Figure 3.3). When examining body 
length and abdominal circumference as a percentage of initial values, there were no 
significant differences between runts, littermate and sow-fed controls (Table 3.4). 
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Figure 3.3: Relative rate of body weight gain (rate of body weight 
gain as a percentage of initial body weight) expressed as line of 
regression in runt, littermate and sow-fed control pigs. 
0 Runt -Runt r2=0.95 
a Littermate --· Littermate r2=0.89 
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Table 3.4: Relative rate of body weight, body length and abdominal circumference gain 
in runts, littermates and sow-fed control piglets during milk feeding. The rate of gain 
expressed is as a percentage of initial weight, length and circumference measurements. 
Runt Littermate Sow-fed 
Relative rate of body 0.20 ± 0.01 D 0.22 ± 0.02 a 0.15 ± 0.01 b 
weight gain r2=0.95 ?=0.89 r2=0.75 
Relative rate of body length 0.02 ± 0.001 0.02 ± 0.001 0.03 ± 0.006 
gam ?=0.80 r2=0.91 ?=0.49 
Relative rate of body 0.03 ± 0.002 0.02 ± 0.002 0.02 ± 0.003 
abdominal circumference r2=0.76 r2=0.83 1=0.80 
gam 
Data within a row a p>0.05 
Absolute growth during milk feeding. 
In terms of absolute body weight and body length runts remained significantly 
smaller than other piglets at week 1, 2, 3, 4 (Table 3.5, 3.6). However, by four weeks the 
there was no significant difference in abdominal circumference between runts and other 
pigs (p=0.06) (Table 3.7). 
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Table 3.5: Average weekly absolute body weights, kg (day 3-10, 11-17, 18-24, 25-31) of 
runt, littermate and sow-fed piglets during milk feeding. 
Average Body Runt Littermate Sow-fed 
Weight (kg) 
Week 1 (Day 3-10) 1.1863 ± 0.1559 a 1.7418 ± 0.2385 D 1.6068 ± 0.4156 D 
Week 2 (Day 11-17) 1.9460 ± 0.3901 a 2.7575 ± 0.8369 D 3.0064 ± 0.8492 D 
Week 3 (Day 18-24) 2.9102 ± 0.6169 a 3.8698 ± 0.9688 D 3.9121 ± 0.9421 D 
Week4 (Day 25-31) 4.1005 ± 0.4723 a 5.3765 ± 0.7964 D 5.2919 ± 1.1096 D 
Table 3.6: Average weekly absolute body lengths, em (day 3-10, 11-17, 18-24, 25-31) of 
runt, littermate and sow-fed piglets during milk feeding. 
Average Body Runt Littermate Sow-fed 
Length (em) 
Week 1 (Day 3-10) 34.5 ± 2.3 a 38.5 ± 2.4 b 36.8 ± 2.8 b 
Week 2 (Day 11-17) 39.5 ± 4.9 a 43.3 ± 4.1 D 43.5 ± 5.6 D 
Week 3 (Day 18-24) 45.7 ± 2.4 a 51.0 ± 2.8 D 50.4 ± 4.2 D 
Week 4 (Day 25-31) 51.3 ± 2.8 a 58.1 ± 2.6 b 55.8 ± 1.8 b 
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Table 3.7: Average weekly absolute abdominal circumference, em (day 3-10, 11-17, 18-
24, 25-31) of runt, littermate and sow-fed piglets during milk feeding 
Average Abdominal Runt Littermate Sow-fed 
Circumference (em) 
Week 1 (Day 3-10) 25.6 ± 0.9 a 29.3 ± 1.4 b 27.5 ± 0.7 b 
Week 2 (Day 11-17) 31.0 ± 3.0 a 35.0 ± 3.9 ° 34.8 ± 3.5 ° 
Week 3 (Day 18-24) 38.0 ± 2.2 a 42.1±3.4° 39.7 ± 2.6 ° 
Week 4 (Day 25-31) 41.7 ± 1.6 ° 45.2 ± 2.2 ° 43.7 ± 3.2 ° 
Growth characteristics during the chow feeding phase (1- 9 months of age) 
Feed intake 
Average daily feed intake (kg/d) did not significantly differ between pigs 
throughout the study. Upon visual inspection, it increased linearly from day 40 until 
approximately day 110 of study. Feed intake then became more variable as animals 
reached sexual maturity (Figure 3.4). Feed efficiency (kg feed per kg gain) steadily 
declined over time and was not different between groups of animals (Figure 3.5). 
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Figure 3.4: Average daily feed intake (kgld) from adaptation to chow 
(day 40) to the end of study in runt, littermate and sow-fed controls. 
o Runt -Runt r2=0 .83 
c Littermate --· Littermate r2=0.82 
t:J. Sow-fed ----- Sow-fed r2=0.80 
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Figure 3.5: Average feed efficiency (kg feed per kg gain) 
during chow feeding in runt, littermate and sow-fed control 
ptgs. 
ADFI =Average daily feed intake 
ADG =Average daily gain 
• Runt r2 = 0.68 
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Growth rates 
Weight gain, body length and abdominal circumference once the piglets were 
adapted to chow increased linearly throughout the study (Table 3.8). Runt pigs grew at a 
significantly slower rate than other pigs from day 40 -110 of study (p=0.002) but not 
from day 110 until the end of study (Figure 3.6). Body length and abdominal 
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circumference increased significantly more rapidly from day 40 until 110 than from day 
110 until the end ofthe study (p<0.0001) (Figure 3.7, 3.8). There were no differences in 
these indices between runts, littermates or sow-fed controls at either time period. 
Table 3.8: Rate of body weight gain (kg/d), body length and abdominal circumference 
gain (em/d) from day 40-110 and 110 until the end of study in runt, littermate and sow-
fed pigs 
Runt Littennate Sow-fed 
Growth rate (kg/d) 
Day 40-110 0.270 ± 0.011 a 0.321 ± 0.011 b 0.309 ± 0.011 b 
r2=0.94 r2=0.95 r2=0.95 
Day 110-220 0.301 ± 0.016 0.301 ± 0.011 0.277 ± 0.017 
r2=0.89 r2=0.95 r2=0.87 
Body length gain (em/d) 
Day 40-110 0.5 ± 0.022 0.5 ± 0.02 0.6 ± 0.02 
r2=0.97 r2=0.94 r2=0.95 
Day 110-220 0.2 ± 0.01 0.2± 0.02 0.2 ± 0.02 
r
2
=0.89 r2=0.71 r2=0.82 
Abdominal Circumference 
gain (em/d) Day 40-110 0.4 ± 0.02 0.4 ± 0.02 0.4 ± 0.02 
r2=0.85 r2=0.93 r2=0.91 
Day 110-220 0.2 ± 0.02 0.19±0.01 0.17 ± 0.03 
r2=0.65 r2=0.75 r2=0.56 
p=0.002 
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Figure 3.6: Lines of regression for rate of body weight gain 
(kg! d) during chow feeding in runt, littermate and sow-fed pigs 
o Runt -Runtr2 =0.89 
c Littermate 
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Figure 3.7: Lines of regression for the rate of body length gain 
(em/d) from adaptation to chow to day II 0 and day II 0 until the end 
of study in runt, littermate and sow-fed control pigs 
-Runt ( d40 - dii 0, r2 = 0.97; dii 0 to end, r2 = 0.89) 
--·Littermate (d40- diiO, r2 = 0.94; diiO to endr2 = 0.7I) 
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Figure 3.8: Lines of regression for the rate of abdominal 
circumference gain (em/d) from adaptation to chow to day 110 and 
day 110 until the end of study in runt, littermate and sow-fed control 
p1gs 
-Runt (d40- d11 0, r2 = 0.85; d11 0 to end, r2 = 0.66) 
--·Littermate (d40- d110, r2 = 0.93; d110 to end r2 = 0.75) 
·----·Sow-fed (d40- d11 0, r2 = 0.91; d11 0 to end r2 = 0.56) 
o Runt 
a Littermate 
" Sow-fed 
Absolute Growth. 
Absolute growth was examined at two time points, day 11 0 and day 220 (Tables 
3.9, 3.10). In analyses where gender had no effect the data was presented as group 
means. When gender had a significant effect, the data was presented as figures (Figures 
3.9, 3.10, 3.11). At day 110, the pigs approximately 3.5 months of age and their rate of 
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length and abdominal growth was just beginning to slow down. Most animals reach 
sexually maturity around 3.5-4 months of age (i.e. when we observed standing heat in 
females). Day 220 was toward the end of the study and the pigs were roughly seven 
months of age. Runts were significantly smaller than other pigs in terms of body weight 
and body mass index at day 110 of study (p=0.0048). Abdominal circumference was not 
different between groups of pigs, but was greater in females than males (p=0.0101) 
(Figure 3.9). Runts were significantly smaller in terms of body length than other pigs 
(p=0.005). Female large littermates were significantly shorter in body length than male 
littermates (p=0.02) (Figure 3.10). Towards the end of study at day 220, there were no 
differences in body weight, length, body mass index or abdominal circumference between 
pigs. Abdominal circumference was greater in females than males (p<0.0001) (Figure 
3.11). 
Table 3.9: The effects (p value) of group (runt, littermate, sow-fed) and gender on 
absolute body weight (kg), body length and abdominal circumference (em) and body 
mass index (kg/m2) on day 11 0 
Runt Littennate Sow-fed Group Gender Group X 
p value p value Gender 
p value 
Body weight 22.81 ± 27.53 ± 26.42 ± 0.005 0.16 0.13 
(kg) 2.00 2.74 2.16 
Body length 90.1 ± 2.9 96.7 ± 6.0 96.2 ± 4.3 0.005 0.008 0.02 
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(em) 
Abdominal 70.8 ± 4.8 75.9 ± 3.4 74.4 ± 5.1 0.08 0.01 0.39 
circumference 
(em) 
Body mass 22.8 ± 1.0 27.5 ± 2.9 26.4 ± 0.8 0.005 0.16 0.13 
index (kglm2) 
Table 3.10: The effects (p value) of group (runt, littermate, sow-fed) and gender on 
absolute body weight (kg), body length and abdominal circumference (em) and body 
mass index (kg/m2) on day 220 
Runt Littermate Sow-fed Group Gender Group X 
p value p value Gender 
p value 
Body weight 58.60 ± 64.86 ± 63.34 ± 0.09 0.60 0.21 
(kg) 5.75 3.55 4.58 
Body length 124.3 ± 4.5 129.4 ± 3.7 129.1 ± 2.3 0.051 0.46 0.25 
(em) 
Abdominal 97.3 ± 6.3 102.1±4.9 99.8 ± 7.0 0.10 p<0.0001 0.48 
circumference 
(em) 
Body mass 58.6 ± 0. 2 64.9 ± 2.2 63.3 ± 4.7 0.09 0.60 0.21 
index (kglm2) 
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Female Male 
Figure 3.9: Abdominal circumference (day 110) in runt, littermate and 
sow-fed control pigs. Female pigs had statistically significantly higher 
abdominal circumference at day 110 than male pigs (p=O.O 1 0). There 
were no statistically significant differences between runt, littermate and 
sow-fed control pigs (p=0.08) 
mB:Runt 
~ Littermate 
=sow-fed 
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Female Male 
Figure 3.10: Body length (em) at day 110 in runt, littermate 
and sow-fed control pigs. Runts were significantly smaller 
than other pigs (p=0.005). Female large littermates were 
significantly shorter in body length than male littermates 
(p=0.02) 
~Runt 
~ Littermate 
=sow-fed 
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Figure 3.11: Abdominal circumference (em) on day 220 in 
runt, littermate and sow-fed control pigs. Female pigs had 
significantly greater abdominal circumference (em) than male 
pigs (p<O.OOOI). 
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~ Littermate 
=sow-fed 
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3.4 Discussion 
Low birth weight is often the result of an insufficient supply of nutrients to the 
fetus. In litter-bearing species such as the pig, naturally occurring low birth weight 
neonates (runts) are born as small as one-third the size of their littennates. Runting is 
thought to be caused by placental insufficiency resulting in decreased oxygen and nutrient 
delivery to the fetus (Foxcroft et al., 2006). Often, runts do not gain access to an 
adequate teat at birth due to litter competition and as a result, have lower feed intakes, 
slower growth and decreased survival rates. In addition to limited postnatal nutrient 
supply, runt piglets are born with less muscle fibres leading to slower growth rates 
making them less capable to achieve the same size as their littermates (Foxcroft et al., 
2006). Powell and Aberle found that runt piglets grow less efficiently and produce 
carcasses with more fat than their littermates (Powell and Aberle, 1980). Because runt 
piglets in our study were provided ad libitum nutrients via individual formula feeding 
(eliminating competition), we did not expect to see this typical marked decrease in gro\\rth 
rate. Therefore, in this chapter we wanted to examine and compare the growth patterns of 
well-nourished runt piglets from birth to early adulthood to their larger litternmtes. 
In response to nutritional insults in utero, neonates will undergo a period of 
accelerated postnatal growth, termed compensatory or catch-up growth. During this 
period, nutrient efficiency (utilization) is increased allowing for rapid gro\\rth. However, 
this increased efficiency is transient and once over, growth continues along a trajectory 
according to age and size. If the animal continues to receive abundant nutrients once the 
period of compensatory gro\\rth is complete, the excess nutrients will be catabolized and 
deposited as fat. We expected runt piglets to experience a period of increased nutrient 
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efficiency during milk feeding, but not completely catch up in size to their littermates as 
adults. Since piglets were being fed ad libitum throughout the study we expected runt 
piglets to deposit fat once the period of compensatory growth finished. Sow-fed controls 
were used as a reference group ofnom1al growth and development. We expected large 
littermates to display similar growth patterns to that of sow-fed control piglets. 
Milk Feeding Phase 
Since compensatory growth typically occurs in early postnatal life, our results 
were divided into "milk feeding phase" and ·'chow feeding phase'' and analyzed 
separately. During milk feeding, runts grew in weight, length and abdominal 
circumference at a significantly slower rate than other piglets, despite being fed ad 
libitum. Similar growth response in domestic runt piglets fed milk replacer ad libitum has 
been observed in other studies (Ritacco, Wolter 2002). Poore and Fowden (2004) found. 
that lower birth weight (not runts) domestic piglets grew at a significantly slower rate 
than higher birth weight piglets during the first month of life. Although, the slower 
growth rate in our runts was expected, the reason is unkno\\-n. It is possibly due to 
reduced absorptive capacity. meaning the runt's maximal absorptive capacity is 
propmtionately lower than their larger litte1mates. It could also have been due to reduced 
muscle fibres in runts. The longissimus dorsi muscle and gastrocnemius muscle ofthe 
pigs were obtained at necropsy as adults. Measuring the number of muscle fibres in these 
muscles could be useful to better understand early postnatal growth patterns in miniature 
p1gs. 
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The growth rates (milk feeding) of runts and sow-fed controls relative to their 
birth weights were similar, whereas, larger littermates grew more slowly relative to their 
birth weight. A faster relative rate of growth indicates catch up growth. Poore and 
Fowden (2004) also found that low birth weight pigs had a significantly quicker relative 
rate of growth compared to high birth weight pigs during the first month of life, indicative 
of compensatory growth. The indication of catch-up growth in sow-fed piglets was 
surprising, but might be due to the fact that these piglets had greater access to more milk 
f):om the sow after the runt and large littemmtes were removed. Litters in miniature pigs 
are smaller (i.e. 5-7 piglets) than those in domestic pigs (1 0-15) and so removal of two 
piglets would lead to greater milk availability for the remaining piglets. Indeed, some 
litters were relatively small (3-5) and in other litters, some of the remaining piglets were 
taken for other studies, leaving only the sow-fed control piglet with the mother. This late 
removal of piglets could lead to a catch-up growth scenario for the remaining sow-fed 
control in this study. 
Absolute weekly body weights, lengths and abdominal circumferences were not 
different between large littermates and sow-fed controls. Runt piglets reii?ained 
significantly smaller than other piglets in terms of length and weight throughout the milk 
feeding period. This observation was expected, as runts do not usually completely catch 
up in body size to their littermates. At 4 weeks of age, there was no significant difference 
in abdominal circumference between groups, suggesting that rw1t piglets were using 
excess nutrients for fat deposition. In order to characterize growth more accurately, more 
sophisticated in vivo measures should be made. For example, dual energy X-ray 
absorptiometry (DEXA) could be used to determine the percentage of fat and lean mass 
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of the animals in vivo over time. Future studies using serial slaughter and subsequent 
carcass composition analysis could also be employed to more accurately determine the 
composition of growth in these animals over time. 
During milk feeding, runt piglets experienced a period of increased feed efficiency 
during the third week of milk feeding, characteristic of compensatory growth. Ritacco 
and colleagues ( 1997) observed a similar period of nutrient efficiency in domestic piglets 
during the first two weeks of milk feeding. Establishing compensatory growth is 
important in this model, because in epidemiological studies, humans who are hom small 
and experience compensatory growth are at an even higher risk for the development of 
chronic diseases than infants who are born of low birth weight alone. 
Chow Feeding Phase 
During the chow feeding phase, we expected pigs to grow linearly throughout 
'childhood' and then to level off towards the end ofthe study once the pigs were past 
sexual maturity. Few studies have examined the growth of runt pigs into adulthood, as 
there are few economic benefits to doing so in swine production. Of the few studies that 
have examined growth to adulthood in domestic swine, runt piglets do not completely 
catch up in body size to their littermates (Powell et al, 1980, Wolter et al 2002). 
Therefore, we expected runt piglets to remain somewhat smaller than their littermates 
throughout the study. 
Growth continued linearly in two phases throughout the entire study, with no 
differences between groups. Body length and abdominal circumference during the chow 
feeding phase was rapid until approximately 3.5 months of age and then slowed from 4 
months until the end of the study (9 months). Feed efficiency steadily declined with age. 
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As expected, large littermates and sow-fed controls displayed similar growth patterns. 
The growth pattern displayed by these pigs is similar to that of humans. As the animals 
aged, their feed efficiency worsened, they stopped growing in length and continued 
gaining weight, likely as fat. In order to better describe the growth pattern, detern1ining 
the composition of gain is necessary. It would have been useful to take DEXA 
measurements throughout the chow feeding phase to characterize the composition of 
----gro\\.1:11-throughout this period. At necropsy the viscera and carcasses were collected 
separately for composition analysis. Once these results have been compiled, the 
percentage lean mass, fat mass and bone ash will be identified, allowing us to confirm the 
composition of gain for the entire protocol. 
By the end of the study, there were no significant differences in body size between 
runts and their littermates. This finding was unexpected, as runts typically do not 
completely catch up in body size to their littermates, but rather usually maintain a gro\\-1h 
tr~jectory based on their weaning size. Wolter and colleagues (2002) examined the 
growth patterns of low and high bitth weight domestic pigs fed ad libitum from 3 days of 
age until market weight (110 kg). They found that low bi1th weight pigs took 
significantly more days to reach market weight than high birth weight pigs. However, 
unlike the Wolter study (2002) we intentionally removed the runts from the sow to allow 
ad libitum feeding and catch up growth. When runts are left on the sow they usually 
cannot compete for a teat. Moreover, market weight was achieved at approximately 5 
months of age, much younger than the pigs used in our study. Poore and Fowden (2004) 
compared the growth pattems of feed-restricted high and low birth weight pigs and found 
no difference in body weight between groups at one year of age. The pigs in their study 
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were at a similar stage of development (past sexual maturity) as our pigs, making their 
results more comparable. It is likely that the reason for complete catch up growth in our 
pigs was due to a combination of ad libitum feeding, decreased feed efficiency and 
increased fat deposition with age. 
It is difficult to draw direct comparisons between the Yucatan miniature pigs used 
in this study to domestic breeds of pigs. Domestic breeds have been genetically selected 
for fast growth rates and protein deposition, whereas, miniature swine have been 
developed as a research model with a demonstrated propensity to obesity. Few studies 
carefully detailing the characteristics and composition of growth in miniature pigs are 
available. However, the results from this study support the use of the miniature pig as a 
model for human growth. 
Epidemiological studies have shown that low birth weight infants who experience 
compensatory gro\\-1h are more likely to develop obesity later in life (Taylor and Poston 
2007). In pigs at 9 months of age (i.e. young adulthood), there were no differences in 
abdominal circumference between runts and larger pigs. Females had a significantly 
higher abdominal circumference than males. However, abdominal circumference is a 
rough estimate of obesity much like waist circumference in humans. In order to 
determine if our pigs developed obesity, carcass composition analysis will be completed. 
These results will reveal the degree of visceral obesity, which is considered a major risk 
factor for diabetes and cardiovascular disease in humans. 
Studies in sheep and rats have suggested that appetite may be programmed in 
utero leading to hyperphagia and obesity in later life (Langley-Evans et al 2005). We 
measured feed intake throughout the entire study but the results were difficult to interpret. 
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From adaptation to chow (5 weeks of age) until roughly 4 months of age (sexual 
maturity), feed intake increased linearly with no differences between groups. After 
sexual maturity, feed intake results were difficult to interpret, as they were highly 
variable. Feed consumption in females was greatly influenced by their ovulation cycles. 
When in heat, females did not consume as much feed as when they were not in heat. 
Male pigs consumed roughly the same amount of feed daily once past sexual maturity. 
However, feed intake was influenced by social behaviours, such as fighting for status 
among the group. Stress also inf1uenced feed intake in the pigs. Animals subjected to 
stress, for example during blood sampling, did not consume as much food after the 
procedure. These are simply observations; a more systematic method of quantifying the 
factors affecting feed intake should be developed. Another factor affecting feed intake in 
swine is temperature. In cold temperatures, pigs tended to consume more feed than in 
warm temperatures. Since the housing facility did not have tightly controlled temperature 
environment, feed intake results were likely affected by environment. Based on our 
results. runt piglets did not appear to be hyperphagic as observed in other animal models, 
although our data were probably too variable to detect modest differences. We found no 
evidence to support that appetite was programmed in utero given our measurement 
protocols. 
Conclusion 
It is not surprising that the Yucatan miniature pig proved to be a successful model 
for studying compensatory growth, as the domestic pig is already a well-characterized 
and established model of compensatory growth in the field of animal science (Foxcroft et 
al., 2006, Mitchell, 2007). Fetal programming has brought about a resurgence of interest 
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in compensatory growth in the hwnan population. Low birth weight infants who 
experience compensatory growth appear to be at an even higher risk for later disease 
development than if they were born of low birth weight alone. In animal models of fetal 
programming such as the rat and pig, accelerated growth postnatally correlates to markers 
of diabetes (Langley-Evans et al 2005). The following chapter explains the relationships 
between birth weight and postnatal growth rates and markers of type 2 diabetes Yucatan 
miniature pigs. 
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Chapter 4.0 Diabetes 
4.1 Introduction 
Diabetes Mellitus is a metabolic disease characterized by a dysregulation in 
glucose, insulin and lipid metabolism. The most prominent types of diabetes are insulin 
dependent diabetes mellitus (type 1 diabetes) and non-insulin dependent diabetes mellitus 
(type 2 diabetes). Type 1 diabetes is an autoimmune disease causing destruction of the 
pancreatic beta cells. Patients with type 1 diabetes are unable to produce insulin resulting 
in hyperglycemia. These patients require insulin therapy to keep them in euglycemia. 
Ninety percent of people suffering from diabetes have type 2 diabetes (World Health 
Organization). The metabolic defect causing type 2 diabetes is unknown but insulin 
secretory capacity and mass of pancreatic beta cells are often reduced (Donath and 
Halban 2004). Insulin resistance typically precedes type 2 diabetes. 
Insulin resistance refers to the impaired glucose uptake by peripheral tissues. 
When insulin resistant, peripheral tissues are no longer sensitive to insulin causing 
impaired glucose uptake and utilization, leaving cells starved for glucose. The pancreas 
compensates by increasing insulin production and secretion causing hyperinsulinemia. 
The pancreas cannot keep up with the insulin demand and insulin production is impaired, 
resulting in hyperglycemia and type 2 diabetes. The cause of insulin resistance is 
unknown. Insulin resistance is considered a risk factor for diabetes development and is 
one of the main components of the metabolic syndrome. 
The metabolic syndrome was first defined in 1988 by Reaven to be a 
dysregulation in glucose, insulin and lipid metabolism combined with hypertension. 
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Since then, the definition has been expanded to include obesity (Desroches and Lamarche 
2007). Extensive research into the metabolic syndrome has identified it as a major risk 
factor for diabetes and cardiovascular disease, gaining prevalence worldwide (Ardem and 
Janssen 2007). Although the epidemiology of the metabolic syndrome is well 
characterized, the metabolic mechanisms are unclear. Currently there are several 
definitions for diagnosing of the metabolic syndrome that all include varying 
combinations of hyperinsulinemia, hyperglycemia, hypertriglyceridemia, obesity and 
hypertension. Identifying components of the metabolic syndrome is useful for the 
prediction of diabetes and cardiovascular disease development. 
There are several tests to measure symptoms of diabetes and the metabolic 
syndrome. Fasting plasma analysis of glucose, insulin and lipids is a simple, quick and 
inexpensive method of identifying symptoms such as hyperglycemia, hyperinsulinemia 
and dyslipidemia. The findings from fasting plasma analysis may warrant the use of 
more sophisticated in vivo measurements of glucose and lipid metabolism such as glucose 
tolerance tests and insulin sensitivity tests. 
Glucose tolerance tests measure the pancreatic beta cell's responsiveness to 
glucose. The oral glucose tolerance test is used to diagnose diabetes in humans. The 
individual consumes a glucose solution and a glucose concentration in the plasma is 
measured over a 2-hour period. If plasma glucose is still elevated(> 11 mmol/L) at 2 
hours, then the individual is considered diabetic (World Health Organization, 2006). Oral 
glucose tolerance tests can be impractical to perform in animals because animals may not 
voluntarily consume the glucose dose orally. Therefore, the intravenous glucose test has 
been used. A glucose bolus is given intravenously and glucose clearance from the plasma 
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is measured. The outcomes in this test respond much more quickly as there are no effects 
of gastric emptying. The rate of glucose clearance is a measure of how responsive the 
pancreatic beta cells are to glucose. Slower rates of glucose clearance indicate impaired 
glucose tolerance. 
Insulin sensitivity tests measure insulin-stimulated glucose uptake by peripheral 
tissues, which is a measure of insulin sensitivity (Co belli et al 2007). A large bolus of 
insulin is given and glucose clearance from the plasma is measured. The rate of glucose 
clearance from the plasma is a measure of insulin-stimulated glucose uptake. Slower 
rates of clearance suggest the individual is insulin sensitive which indicates insulin 
resistance. The gold standard method for assessing glycemic status is the 
hyperinsulinemic eugylcemic clamp method. In this method, somatostatin is infused to 
inhibit endogenous insulin secretion, insulin is continuously infused to create 
hyperinsulinemia, and glucose is infused and frequently and rapidly measured in the 
blood in order to keep the individual in euglycemia (Cobelli et al2007). The rate of 
glucose infusion needed to maintain steady state is a direct measurement of whole body 
glucose uptake, which describes the individual's insulin sensitivity. The clamp method 
has beeh used successfully in several species including humans, rats and pigs (Cobelli et 
al 2007). However, this method is very expensive and requires trained personnel. 
Several animal models have been used to study various aspects of diabetes. Rats 
and mice are the most extensively used animal models. Type 1 diabetic rat and mice 
models include spontaneous diabetic strains, chemically induced diabetes and transgenic 
models. Transgenic and knockout models have provided great insight into the genetic 
causes of type 1 diabetes (Gannon 2001). Type 2 diabetic rat and mice models are well 
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characterized and include transgenic models, chemical induction, high fat feeding, 
overfeeding, and fetal programming. Rat and mice models are advantageous for studying 
type 2 diabetes as they have a shorter life span, are small and easy to handle and are a 
well-established model for studying human physiology. However, rodents have different 
feeding behaviours, nutrient requirements and pancreatic development than humans. 
The miniature pig is a more recent model for studying diabetes (Bellinger et al. 
2006). The pig makes an excellent model for studying the metabolic mechanisms of 
diabetes because of their similar physiology, feeding habits (omnivores) and nutrient 
requirements to humans. Also, the pig's pancreas resembles the human's in size, shape, 
position and function (Larsen and Rolin 2004). The majority of studies using miniature 
pigs focus on therapeutic treatments for type 1 diabetes (Larsen and Rolin 2004) and 
chemical induction of type 1 diabetes is the most common technique. Type 2 diabetic pig 
models are not as common. Unlike rat strains, there are few reported cases of 
spontaneous diabetes in pigs. This finding is likely due to the expense and resources 
associated with housing adult pigs. Recently, researchers have used high fat feeding and 
overfeeding to induce obesity in miniature pigs, accelerating diabetes development 
(Sebert et al. 2005). Poore and Fowden (2002) observed impaired glucose tolerance at 1 
year of age in low birth weight pigs. Their findings suggest that low birth weight may 
accelerate diabetes development in pigs. The potential use of the pig as a model for type 
2 diabetes warrants further research. 
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4.2 Chapter Objectives 
1. Validate the use of the miniature pig as a model for type 2 diabetes. 
2. Determine the effects of birth weight and postnatal growth rate on the 
development of type 2 diabetes 
3. Determine the impact of early postnatal nutrition and mode of feeding on the 
susceptibility to type 2 diabetes. 
4.3. Methods 
Animals and housing. 
For detailed information on animals and housing see Chapter 3: Compensatory 
Growth. 
Oral Glucose Tolerance Test (OGTT) 
At approximately six months of age, an oral glucose tolerance test was performed 
after an overnight fast. Ear pricks were made with a lancet and blood glucose was 
measured instantly with an Ascensia Contour blood glucose meter (Bayer, Toronto ON). 
Two fasting measurements were made before administering 2 g/kg D-Glucose (Sigma) 
dissolved in 1 00 ml of tap water via gavage. Ear prick glucose measurements were made 
every 10-15 minutes for roughly 2.5 hours until blood glucose values returned to fasting. 
Surgical Procedures. 
At approximately eight months of age, animals were transported to the Health 
Sciences Center at least one day before surgery and were fasted overnight. Pigs were 
anaesthetized using an induction dose of20 mg/kg ketamine hydrochloride (Ketalean, 
Bimeda-MTC Cambridge ON) and 2 mg/kg xylazine (Rompum, Bayer Toronto ON) and 
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maintained with 0.5 - 1.5 % halothane gas and 3/2 oxygen/nitrous oxide. A small 
incision was made on the inside of the left leg in order to isolate the femoral vessels. 
Two 2.4 meter tygon catheters, internal and outer diameters of0.040 and 0.070 (Norton 
Performance Plastics, Akron Ohio), respectively, were inserted into the femoral vein and 
advanced to the inferior vena cava. Catheters were tunnelled under the skin and 
exteriorized by a small incision on the animal's back between the shoulder blades. The 
catheter of a TA11PA-D70 radiotelemeter implant (cat# 270 0044 835, Data Sciences 
International, St. Paul MN) was inserted into the femoral artery and advanced to the 
femoral artery. The telemeter body was implanted under the skin between the peritoneum 
and inner thigh. Before surgery and two days immediately following surgery, 0.067 
mL/kg trimethoprim sulfadoxine (Borgal, Intervet Canada Ltd. Withy ON) was given. 
300 J..Lg buprenorphrine hydrochloride (Temgesic, Schering-Plough Ltd. UK) was given 
immediately after surgery and again 24 hours later to alleviate pain. 
Experimental Design 
Animals were allowed to recover for 4-5 days after surgery before any in vivo 
testing began. The in vivo testing period included several other tests not considered in 
this thesis including blood pressure by telemetry and fat tolerance tests and lasted 
approximately one month. During this period catheters were flushed daily with 5 mL of 
0.2% heparinized saline. Body temperature was also measured daily with a digital ear 
thermometer and Hibitane antibiotic/antifungal cream (Ayerst, Guelph ON) was rubbed 
on all wound sites to monitor and prevent infection. Antibiotics were only given if the 
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animal presented a temperature of greater than 40°C. The five-hour daily feeding regime 
was re-established the day immediately following surgery. 
Five days after surgery, provided the animal had no fever, an intravenous glucose 
tolerance test (IVGTT) was performed after an overnight fast. Two fasting 4 mL blood 
samples were taken in EDTA tubes before intravenous administration of 0.5 g/kg body 
weight 50% glucose solution. Blood was sampled from the other catheter every five 
minutes and blood glucose was measured using an Ascensia Contour blood glucose meter 
(Bayer, Toronto ON). The test was stopped when blood glucose returned to fasting 
levels. Blood samples were centrifuged for 10 minutes at 4000 x g at 4 °C. The plasma 
was obtained and stored at -20 °C for later analysis of plasma glucose and insulin. 
Six days after surgery an insulin sensitivity test (IST) was performed after an 
overnight fast. A fasting 4 mL blood sample was taken in EDT A at time -10 min. Next, 
somatostatin was administered intravenously ( 4J..Lglk:g) at time -5 min to inhibit the 
endogenous release of insulin from the pancreas. At time 0, a 0.5 g/kg 50% glucose 
solution was given intravenously. Blood samples were taken every 3 minutes and whole 
blood glucose was measured instantly with an Ascensia Contour glucose meter. 
Somatostatin has a short half life and therefore, a maintenance dose was given after each 
blood sample. When blood glucose concentrations stabilized, Humulin R insulin (Eli 
Lilly, Toronto ON), 0.5 U/kg body weight was given intravenously. Blood samples were 
then taken every 5 minutes until blood glucose concentrations returned to fasting levels. 
Blood was centrifuged for 10 minutes at 4000 x g at 4 °C. The plasma was obtained and 
stored at -20 oc for later analysis of plasma glucose, insulin and C-peptide. 
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Two days following the 1ST, a fat tolerance test was performed after an overnight 
fast. Two days after the fat tolerance test, continuous 48-hour baseline blood pressure 
recordings began. Only one pig could be recorded at a time, therefore, pigs were rotated 
into and out of the recording pen. Immediately following baseline measurements, pigs 
were fed a high salt diet for 8 days. Blood pressure was recorded continuously for the last 
48 hours of high salt feeding. Once high salt feeding ceased, pigs were fed their regular 
chow for at least three days before being killed. Since my primary objective was to look 
for the development of type 2 diabetes in these pigs, I will only discuss the results of the 
IVGTT and 1ST. 
Necropsy 
Pigs were anaesthetized with 105 mg/kg sodium pentobarbital (Euthanyl, 
Biomeda-MTC Cambridge ON) and ventilated and maintained with 0.5 - 1 % halothane 
gas mixed with oxygen. Organs were removed from anaesthetized animals and samples 
stored in 10% neutral buffered formalin and/or liquid nitrogen for later analyses. Animals 
died by exsanguination. Carcasses and visceral organs were homogenized separately and 
frozen ( -20°C) for later composition analysis. 
Biochemical Analyses 
Fasting plasma glucose and insulin were measured at 6 months of age and in the 
initial fasting sample of the IVGTT (approximately 8.5 months). Plasma glucose and 
insulin were measured in all samples during the IVGTT and 1ST. In order to verify that 
endogenous insulin secretion was suppressed during the 1ST, C-peptide was measured in 
plasma. Plasma glucose was measured using a Rapid Lab blood biochemistry analyzer 
(Bayer Diagnostics, Toronto ON). Plasma insulin was measured using a porcine insulin 
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radioimmuoassay kit (Linco Research, St. Charles Missouri). Briefly, a known 
concentration of radio labelled insulin and an unknown amount of insulin in plasma 
compete for a fixed amount of binding sites on anti-insulin antibody. The radiolabelled 
insulin and plasma insulin reach equilibrium such that the amount of radio labelled insulin 
bound decreases as the amount of plasma insulin increases. A standard curve is 
constructed with fixed concentrations of insulin and radio labelled insulin. Radioactivity 
is counted and plasma insulin concentrations can be determined using the standard curve. 
C-peptide was also measured using a porcine insulin radioimmunoassay kit (Linco 
Research, St. Charles Missouri) using similar principles. 
Statistical Analysis 
All statistical analyses were performed using Graph Pad Prism 4 software 
(GraphPad Software, Inc. San Diego, CA). Area under the curve (AUC) was calculated 
when glucose versus time plots were made using Graph Pad Prism 4 software. 
Comparisons between groups of pigs and gender were made by non-repeated measures 2 
way ANOVA using Graph Pad Prism 4. This test could not compare litter effect because 
sow fed piglets were not the same sex for two groups (one for each gender); as a result the 
non-repeated measures approach was used to compare overall group effect and overall 
gender effect (which was balanced). Table 4.1 illustrates the gender imbalance. 
Comparisons between runt and littermate (i.e. the litter effect) and gender were made 
using repeated measures 2 way ANOV A; this test was possible because all pairs of runt-
littermates were same-sex. When gender tested non-significant, paired students t tests 
were used to make runt and littermate comparisons. Linear regression was used to 
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determine correlations. Statistical significance was declared ifp < 0.05. All data are 
expressed as mean, plus or minus standard deviation. 
Table 4.1: Representation of gender inequality. Similar numbers represent siblings, for 
example, Runt 1 is sibling ofLittennate 1 and Sow-fed 1 (all females). Sow-fed control 
pigs from litters 3 and 6 are of different gender than the runts and littennates of litters 3 
and 6. 
Runt Littennate Sow-fed 
Female 1 2 3 1 2 3 1 2 6 
Male 456 456 453 
4.4 Results 
Pilot Data from OGTT 
Results from the OGTT were highly variable (Table 4.2). Fasting glucose was not 
different between animals. The areas under the curve for glucose were extremely 
variable, with littennates experiencing the most variance. Time to baseline was not 
different between animals. 
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Table 4.2: Pilot results from the oral glucose tolerance test (OGTT) performed on runt, 
littermate and sow-fed pigs at 6 months of age. 
Runt (N=4) Littermate (N=3) Sow-fed (N=4) 
Body Weight (kg) 39.8 ± 5.7 44.0 ± 4.4 44.5 ± 8.4 
Glucose Given (g) 79.50 ± 11.36 88.00 ± 8.72 89.00 ± 16.69 
-Fasting Glucose (mmol/1) 2.5 ± 0.3 2.9± 0.5 2.8 ± 0.4 
AUC 106.5 ± 40.6 173.1 ± 130.5 105.2 ± 48.8 
Time to Baseline (min) 114± 19 144± 7 103 ± 29 
Fasting Plasma Analyses 
Fasting plasma glucose and insulin were examined at 6 and 8.5 months of age. At 
six months of age there were no differences in plasma glucose, insulin or glucose: insulin 
between runt, littermate and sow-fed (Table 4.3). Sow-fed pigs were then excluded from 
the analysis and repeated measures 2 way ANOVAs were performed to examine 
differences between runts, littermates and gender. Plasma glucose and glucose: insulin 
was still not different between runts and litterinates. Larger littermates had significantly 
higher fasting insulin than runts (p=0.045). 
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Table 4.3. Fasting plasma concentrations of glucose (mmol/L) and insulin (JlU/mL) and 
glucose: insulin ratio in runt, larger littermate and sow-fed pigs at 6 months of age. 
Runt Littermate Sow-fed 
Plasma glucose (mmol/L) 6.4 ± 2.5 5.3 ± 0.79 5.5 ± 1.0 
Plasma insulin (JlU/mL) 21.60 ± 14.37 3 36.55 ± 12.60 b 29.93 ± 12.42 
Glucose: Insulin 0.41 ± 0.30 0.17 ± 0.09 0.23 ± 0.15 
At 8.5 months of age there were no differences in plasma glucose, insulin or 
glucose: insulin between runt, littermate and sow-fed (Table 4.4). When sow-fed pigs 
were removed from the analysis and repeated measures two way ANOV As were 
performed, there were still no differences between runts and littermates. 
Table 4.4: Fasting plasma concentrations of glucose (mmol/1) and insulin (JlU/ml) and 
glucose: insulin ratio in runt, larger littermate and sow-fed pigs at 8.5 months of age. 
Runt Littermate Sow-fed 
Plasma glucose (mmol/1) 5.4 ± 0.2 5.3 ± 0.4 5.3 ± 0.2 
Plasma insulin (JlU/ml) 14.47 ± 4.92 18.18±8.67 13.37 ± 3.23 
Glucose: Insulin 0.41 ± 0.1 0.36 ± 0.18 0.41 ± 0.09 
Fasting glucose did not change over time and remained in the normal non-diabetic 
range for plasma glucose. Insulin decreased significantly from 6 months to 8.5 months. 
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The ratio of fasting plasma glucose to insulin increased significantly from 6 to 8.5 months 
in littermates only (Figure 4.1 ). Fasting insulin was hypothesized to increase, not 
decrease over time. 
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Figure 4.1: The ratio offastingplasmaglucose (mmol/1): fasting 
plasma insulin (f.lU/ml) at 6 and 8.5 months of age in runt, littermate 
and sow-fed control pigs. The ratio was significantly higher at 8.5 
months than 6 months in littermates only. 
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Intravenous Glucose Tolerance Test (IVGTT) 
Time for glucose and insulin to return to baseline, area under the curve (AUC) for 
glucose and insulin (calculated from initial baseline measurement to the final plasma 
sample), the ratio of AUC of glucose to AUC insulin, peak glucose and insulin, time to 
peak glucose and insulin and the rate of glucose clearance were also determined (Table 
4.5). All of these measurements were later correlated to fasting insulin and fasting 
glucose (Table 4.6). There were no differences in any measurement from the intravenous 
glucose tolerance test between groups of pigs. Sow-fed pigs were removed from the 
statistical analysis and repeated measures two way ANOV As were done to look for 
differences between runt, littermate and gender. However, there were still no differences 
between runts and littermates. Gender had an effect on glucose area under the curve 
(AUC), peak glucose (mmol/1) and the ratio of insulin AUC to glucose AUC (Table 4.7). 
Females had a higher AUC for glucose (p=0.0349) and peak glucose than males 
(p=0.0030). The ratio of insulin AUC to glucose AUC was higher in males than females 
(p=0.0172). In 5 pigs, insulin did not return to baseline before the test was stopped 
(Table 4.8). The test was stopped when glucose concentrations returned to baseline. 
These five animals were still included into the statistical analyses. Therefore, the insulin 
area under the curve was underestimated in these animals. 
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Table 4.5: Measurements of glucose tolerance derived from intravenous glucose 
tolerance tests (IVGTT) performed in runt, littermate and sow-fed pigs at 8.5 months of 
age. 
Runt Littermate Sow-fed 
Glucose AUC 461.97 ± 227.48 461.35 ± 165.09 510.78 ± 142.61 
Insulin AUC 4287 ± 1152 4125 ± 716.3 4338 ± 2000 
Insulin AUC: Glucose AUC 11.08 ± 6.13 9.73 ± 3.17 8.98 ± 0.52 
Peak glucose (mmol/1) 30.9 ± 6.0 32.1 ± 7.8 32.5 ± 2.2 
Time to peak glucose (min) 3.0 ± 1.3 3.0 ± 1.3 3.1 ± 1.7 
Peak insulin (J.!U/ml) 204.30 ± 43.64 185.75 ± 7.58 194.05 ± 98.04 
Time to peak insulin (min) 16.4 ± 7.6 13.7 ± 9.8 12.6 ± 3.2 
Slope ln bG -0.048 ± 0.014 -0.051 ± 0.017 -0.051 ± 0.015 
Glucose time to baseline 41.5 ± 16.3 37.3 ± 11.5 38.3 ± 10.0 
(min) 
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Table 4.6: Measurements of glucose tolerance derived from the intravenous glucose 
tolerance test (IVGTT) were correlated to fasting plasma glucose (mmol/1) and fasting 
plasma insulin (!J.U/ml) at 8.5 months of age. 
Fasting Insulin (!J.U/ml) Fasting Glucose (mmol/1) 
Fasting plasma glucose (mmol/1) Sow-fed 
at 6 months -- R2=0.77 
p=0.02 
Fasting insulin (!J.U/ml) at 6 -- --
months 
Glucose area under the curve Runt 
(AUC) -- R2= -0.85 
p=O.Ol 
Insulin area under the curve 
-- --
(AUC) 
Insulin AUC: Glucose AUC -- --
Peak glucose (mmol/1) All pigs 
-- R2= -0.28 
p=0.02 
Time to peak glucose (min) Littermate 
R2= -0.93 --
p=0.002 
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Peak insulin (11U/ml) -- --
Time to peak insulin (min) Sow-fed(+) Runt 
R2=0.83 R2= -0.67 
p=0.01 p=0.05 
Rate of glucose clearance Runt(+) Littermate 
-- R2=0.66 R2= -0.72 
p=0.049 p=0.03 
Glucose time to baseline (min) Runt 
--
R2= -0.92 
p=0.002 
-- indicates no significant correlation 
Table 4.7: Gender differences in measurements of glucose tolerance derived from 
intravenous glucose tolerance test performed at 8.5 months of age 
Female Male P value 
Glucose AUC 578.9 ± 26.9 377.1 ± 73.0 0.0349 
Peak glucose (mmol/1) 36.2 ± 2.4 27.5 ± 2.8 0.0030 
Insulin AUC: Glucose AUC 7.21 ± 0.66 15.41 ± 5.57 0.0172 
Table 4.8: Final insulin concentrations (11U/ml) were elevated above fasting 
concentrations before the intravenous glucose tolerance test was stopped in 1 runt, 2 
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larger littennates and 2 sow-fed control pigs. The difference in insulin concentration 
(f..lU/ml) from initial concentrations and when the test was stopped. 
Glucose Time to Final Insulin Fasting Insulin Difference 
Baseline (min) (f..lU/ml) (f..lU/ml) (f..lU/ml) 
Runt (male) 32 37.22 15.09 22.13 
Littennate (female) 32 66.50 7.80 58.70 
Littennate (male) 29 59.83 34.69 25.14 
Sow-fed (male) 32 23.71 10.23 13.48 
Sow-fed (female) 57 19.24 6.556 12.68 
When looking at all pigs there were no significant correlations between any 
measurement made during the IVGTT and fasting insulin (Table 4.6). Therefore, 
correlations were sought in runts, littennates and sow-fed controls separately. As fasting 
insulin increased in littennates the time to reach glucose decreased (r2=0.93, p=0.002). In 
sow fed controls, the time to reach peak insulin increased with increasing fasting insulin 
concentrations (r2=0.83, p=0.01). All measurements made during the IVGTT were next 
correlated to fasting plasma glucose. The time to peak plasma glucose was negatively 
correlated to fasting plasma glucose (r2=0.28, p=0.02). There were no other significant 
correlations when looking at all the pigs together. In runts, glucose area under the curve, 
time to peak insulin and glucose time to baseline were negatively correlated to fasting 
glucose. The rate of glucose clearance was positively correlated to fasting glucose in 
runts, but negatively correlated to fasting glucose in littennates. In sow-fed controls 
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fasting glucose at six months was positively correlated to fasting glucose before the 
IVGTT. 
Insulin Sensitivity Test (1ST) 
C-peptide concentration (J.lg/ml) remained constant throughout the insulin 
sensitivity test (Figure 4.2). The rate of glucose clearance was determined by plotting the 
natural log of blood glucose values against their respective t time point. The slope after 
the insulin administration was considered the rate of glucose clearance in response to 
insulin. Female sow-fed control pigs had a significantly higher rate of glucose clearance 
than sow-fed male pigs (p=0.04). There were no differences between runts and 
littermates (Figure 4.3). The rate of glucose clearance did not correlate to fasting insulin 
or glucose. 
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Figure 4.3. The average rate of glucose clearance during an 
insulin sensitivity test (ISl) in runt, littermate and sow-fed 
control pig. Female sow-fed pigs had a statistically significantly 
higher rate of glucose clearance than male sow-fed pigs 
(p=0.04) 
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Correlations 
In order to determine the relationships of birth weight and postnatal growth rate to 
symptoms of type 2 diabetes, birth weight and postnatal growth rates were correlated to 
all measurements of type 2 diabetes including fasting plasma glucose, insulin and all 
measurements from the IVGTT and 1ST (Table 4.9). When looking at all pigs there were 
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no significant correlations found between any measurement of diabetes and birth weight, 
growth rate or abdominal growth rate. 
Table 4.9. Correlations were made between measurements of glucose tolerance and birth 
weight (kg), postnatal growth rate (kg/d) during milk feeding, and abdominal 
circumference growth rate (em/d) during milk feeding. 
Birth weight Growth rate during Abdominal 
(kg) . milk (g/d) circumference 
growth rate (em/d) 
Insulin 8.5 months (!-LU/ml) 
-- -- --
Glucose AUC 
-- -- --
Insulin AUC 
--
Littermate 
--
R2=0.74 
p=0.03 
Insulin AUC: Glucose -- -- --
AUC 
Peak glucose (mmol/1) -- -- --
Peak insulin (!lU/ml) -- -- Runt 
R2= -0.09 
p=0.006 
Time to peak insulin (min) Littermate -- --
R2=0.76 
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p=0.02 
Glucose clearance (IVGTT) 
-- -- Runt 
R2= -0.81 
p=0.02 
Glucose clearance (IST) -- -- --
-- means no stgmficant correlatiOn 
Correlations were then made between all measurements of diabetes and current 
weight, current abdominal circumference and current body mass index (Table 4.1 0). 
Again when looking at all pigs there were no significant correlations observed. 
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Table 4.1 0. Correlations were made between measurements of glucose tolerance and 
body weight (kg), abdominal circumference (em) and body mass index (kg/m2) at 8.5 
months of age. 
Current weight Current abdominal Current BMI 
(kg) circumference (kg/m2) 
(em) 
Insulin 8.5 months -- Runts --
{!JU/ml) R2= -0.81 
p=0.01 
Glucose AUC Littermate 
--
Littermate 
R2= -0.69 R2=0.72 
p=0.04 p=0.03 
Insulin AUC -- -- --
Insulin AUC: Glucose -- -- Littermate 
AUC R2= -0.75 
p=0.03 
Peak glucose (mmol/1) -- Sow-fed --
R2=0.66 
p=0.05 
Peak insulin (!JU/ml) -- Littermate --
R2=0.72 
p=0.03 
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Time to peak insulin 
-- -- --
(min) 
Glucose clearance 
-- -- --
(IVGTT) 
Glucose clearance (IST) Littermate -- Sow-fed 
R2=0.83 R2=0.79 
·------------
--
p=O.Ol p=0.02 
-- means no significant correlation 
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4.5. Discussion 
Validating the miniature pig as a model for type 2 diabetes 
When an individual is type 2 diabetic, glucose is not readily transferred into cells 
because there is a lack of response to insulin. Initially the pancreas overcompensates by 
producing excess insulin in an attempt to drive glucose into cells and to keep the 
individual in euglycemia. At this point the individual is considered insulin resistant, 
characterized by high fasting plasma insulin, normal fasting plasma glucose and a low 
ratio of glucose to insulin. An individual can remain insulin resistant for years before 
developing diabetes. Eventually the pancreas cannot keep up with the insulin demand 
and decompensates insulin production. Since cells are no longer normally responsive to 
insulin, there is reduced glucose uptake resulting in hyperglycemia and type 2 diabetes. 
The liver responds by increasing gluconeogenesis adding to the hyperglycemia and cells 
begin using fatty acids as an energy source. Diabetic individuals present dyslipidemia, 
high concentrations of fasting glucose, low concentrations of plasma insulin and a high 
ratio of glucose to insulin. In humans, fasting plasma analysis of insulin, glucose and 
lipids is the first step in assessing an individual's glycemic status. 
Fasting plasma insulin and glucose concentrations were measured in our pigs at 6 
Guvenile) and 8.5 months of age (young adult). Since insulin resistance generally 
precedes type 2 diabetes, we expected to see indicators of insulin resistance such as high 
fasting plasma insulin and a low ratio of glucose to insulin before seeing evidence of type 
2 diabetes. Type 2 diabetes would be suspected if fasting glucose was higher than 
normative values found in the literature combined with a high ratio of glucose to insulin. 
Hematological and serum biochemistry values of healthy sexually mature Yucatan pigs 
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were determined by Radin and colleagues (1986). They found serum glucose ranged 
from 2.40 to 7.40 mM (ll = 3.71 mM) and was not different between males and females at 
80 weeks of age. A normal range of3.0-5.0 mM for glucose and 5 -16j..lU/mL for 
insulin has been observed in recent studies using the Yucatan miniature pig as a model for 
diabetes (Xi et al 2004, Larsen et al2002, Otis et al2003). When diabetes was induced in 
other wise healthy Yucatan swine by using streptozotocin treatment, fasting plasma 
glucose was markedly higher, 15-20 mM, while insulin remained normal (Larsen et al 
2002, Otis et al2003). The pigs in our study had fasting glucose of approximately 5.7 
mM at 6 months and 5.3 mM at 8.5 months. The observed glucose concentrations were 
within the normal range for glucose found in the literature. Fasting glucose over the 
course of the study (3 months- 8 months) did not change significantly and was not 
different between groups of pigs. At 6 months of age, fasting insulin was 31.2 j..lU/mL, 
much higher than the values of healthy pigs used in other studies (Larsen, et al2002, Otis, 
et al2003). Plasma insulin was within the normal range for miniature swine 15.3 j..lU/ml 
at 8.5 months of age. When examining the ratios of glucose and insulin at 6 and 8 
months, the results were unexpected. At 6 months of age, the ratio of glucose to insulin 
was very low (0.18), suggesting the pigs were insulin resistant. However, insulin 
resistance was not present at 8.5 months of age. The brief period of insulin resistance was 
surprising, as insulin resistance was expected to develop into diabetes. 
At 6 months of age the majority of the pigs were coming into sexual maturity 
(puberty). Sebert and colleagues (2005) observed a similar spike in plasma insulin in 
healthy non-castrated male Yucatan miniature pigs undergoing sexual maturity (N=5). 
Plasma glucose, insulin and lipids were measured at 4, 10 and 16 months of age. At 4 
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months, plasma insulin and glucose were within the normative values found in the 
literature. However, at sexual maturity plasma insulin was elevated to 28.8 J.I.U/ml ± 7.82, 
while glucose remained approximately 4.5 mM. Extensive research has been performed 
investigating hormonal changes affecting growth during puberty in swine. However, 
Sebert and colleagues are the only researchers, to my knowledge, to examine insulin 
sensitivity during puberty in swine from a diabetes perspective. Insulin resistance during 
- ---piiberlfis thought to be influenced by growth hormone, insulin-like growth factor-1 
(IGF-1) and changes in body fat distribution. Moran and colleagues (1999) performed the 
hyperinsulinemic euglycemic clamp method (the gold standard method for assessing 
insulin sensitivity) in 357 children. Puberty was associated with high fasting serum 
insulin concentrations and insulin resistance, irrespective of body weight. A recent 
longitudinal study by Hannon and colleagues (2006) found significant differences in 
glucose homeostasis in prepubescence compared to pubescence using the 
hyperinsulinemic euglycemic clamp method. Puberty was associated with a 50% 
decrease in insulin sensitivity compensated by a doubling in insulin secretion. Similar 
studies in pig models of diabetes are needed to better understand the mechanisms of 
insulin resistance during puberty. Also, the onset of sexual maturity in miniature pigs 
needs to be defined. In future studies, careful notes should be taken as to when signs of 
sexual maturity are occurring and when they subside. Identifying when sexual maturity is 
occurring may help to understand and explain unanticipated results. To further enhance 
our study, additional biochemical analyses should be conducted at several time points 
throughout the study to better characterize the observed episode of insulin resistance. In 
addition, fasting plasma IGF-1, and lipids including cholesterol and triglycerides should 
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be analyzed throughout the study to understand changes in metabolism and identify 
indicators of disease development. 
In humans, fasting plasma analysis is a quick and cost-effective screening method 
for chronic disease development. However, it only provides a snap shot of an animal's 
glycemic status. Therefore, in vivo tests are executed to better assess glucose tolerance 
and insulin sensitivity. Two practical in vivo methods for determining glycemic status 
were successfully performed in our pigs: the intravenous glucose tolerance test (IVGTT) 
and insulin sensitivity test (IST). In contrast, the oral glucose tolerance test proved to be 
impractical, stressful and ultimately unsuccessful in our pigs. An oral glucose tolerance 
test (OGTT) measures the pancreas' responsiveness to glucose and is the most common 
test used to assess glucose tolerance and subsequently diagnose diabetes in humans. 
During our OGTT, the oro-gastric gavage technique was used to administer glucose with 
limited success, as it was too difficult to restrain the animals and accurately determine the 
amount of glucose consumed by the animal. Also, the gavage technique was extremely 
stressful, as was the ear prick glucose measurements made throughout the test. 
Glucocorticoids from such stress stimulate gluconeogenesis in the liver. As a result, 
blood glucose concentrations rise above normal within minutes of being subjected to the 
stressor. Since the animals were extremely stressed during the initial dosing phase, it was 
not possible to interpret the results from the oral glucose tolerance test. A variation of the 
oral glucose tolerance test termed the mixed meal has been used successfully in Gottingen 
miniature pigs (Kjems, et al2001, Larsen, et al2002, Xi et al2004). After an 18-24 hour 
fast, animals were offered a mixed meal of 2 g/kg glucose and 25 g standard pig chow 
and blood glucose was monitored over a 2 hour period. Typically during the mixed meal 
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glucose tolerance test, the animals are surgically fitted with a venous catheter for easy, 
non-strenuous blood sampling. The mixed meal method was attempted in our pigs after 
an overnight fast at 6 months of age and later at 8.5 months of age when the pigs were 
surgically fitted with catheters. However, the animals did not consume the mixed meal 
even when the fast was extended to 24 hours. Therefore, the mixed meal test was 
abandoned. An alternative to the oral glucose tolerance is the intravenous glucose 
tolerance test (IVGTT). 
Like the OGTT, the IVGTT measures the pancreatic beta cell responsiveness to 
glucose. During an IVGTT, glucose is infused intravenously causing a rapid rise in 
plasma glucose followed by an incremental decrease in plasma glucose typically over a 
one hour period. Plasma insulin displays a similar curve to that of plasma glucose 
throughout the test. The IVGTT is much quicker than OGTT as there are no effects of 
gastric emptying rates and intestinal absorption. In our animals, the IVGTT provided a 
quick, non-stressful method for determining glucose tolerance. The IVGTT generated 
many results, the most significant of which being glucose and insulin time to baseline, 
glucose and insulin area under the curve (AUC), and the rate of glucose clearance. When 
an animal is glucose intolerant, insulin secretion and function is impaired leading to 
impaired glucose uptake. When glucose is infused, a glucose intolerant animal will be 
unable to or will take longer to clear glucose from the plasma resulting in a slow rate of 
glucose clearance, an inability for glucose to return to baseline, and a large glucose AUC. 
All individual pigs in this study displayed normal glucose curves and glucose 
returned to fasting levels within one hour after infusion. The rate of glucose clearance 
was similar to that of non-diabetic control animals used by Otis and colleagues (2003). It 
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is difficult to compare glucose AUC values found in our study to those found in literature 
due to differences in study methodology. The glucose AUC is affected by the 
concentration of glucose infused and how the AUC is calculated. Johansen and 
colleagues studied 9-1 0 month old female Gottingen miniature pigs fed either a low fat 
(13% fat) or a high fat (55%) diet for 5 weeks. At the end of the 5 weeks an IVGTT was 
performed using a 0.3 g/kg glucose bolus. The glucose AUC was measured over a 120 
minute period after glucose infusion. Pigs fed the high fat diet had a higher AUC for 
glucose than pigs fed the low fat diet, 636 ±.26 and 578 ± 10, respectively. The authors 
did not explain how AUC was calculated. Poore and Fowden (20042) performed an 
IVGTT (0.5 g/kg) in low and high birth weight domestic pigs at 3 and 12 months of age. 
The glucose AUC was calculated from the mean of the pre-infusion fasting glucose 
values until 120 minutes after glucose infusion. At 12 months of age low birth weight 
pigs had significantly higher glucose AUC than high birth weight pigs, approximately 
280 and 200, respectively. The overall average glucose AUC of all our pigs was 478 ± 
172. Females had a statistically significantly higher AUC than males (p<0.05), 578.94 ± 
26.86 and 377.12 ± 72.96, respectively. Our methodology was most similar to that of 
Poore and Fowden (2004), yet our pigs experienced much higher glucose AUC. 
However, there is not enough evidence to define the glucose tolerance of our animals. 
Insulin AUC in our pigs was difficult to interpret. In the majority of our animals, plasma 
insulin followed the expected decay curve and returned to fasting levels within one hour. 
However, five of the pigs had plasma insulin concentrations still elevated when the test 
was stopped, even though plasma glucose had returned to fasting levels. The ratio of 
glucose to insulin when the test was stopped was low, suggesting these pigs were 
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somewhat insulin resistant. In future studies, the test should be extended after glucose 
has returned to fasting levels to better assess insulin sensitivity. 
Insulin sensitivity tests (1ST) are different from glucose tolerance tests in that they 
measure the insulin-stimulated glucose uptake by the muscle. In most insulin sensitivity 
tests, a large bolus of insulin is given and glucose clearance in response to that insulin is 
examined. The rate of glucose clearance from the plasma represents glucose uptake by 
peripheral tissues. Otis and colleagues (2003) administered several doses of insulin (0, 
0.05 and 0.10 U/kg) to diabetic and non-diabetic control, young adult Yucatan miniature 
pigs. They found that 0.10 U/kg insulin induced comas and seizures in non-diabetic 
animals due to severe hypoglycemia. This observation led them to develop a novel 
alternative insulin sensitivity test where non-diabetic pigs were made hyperglycemic 
before giving insulin. Since our animals had normal fasting plasma glucose values, we 
did not suspect the animals to be overtly diabetic. Therefore, we used this alternative 
insulin sensitivity test in our study. First, somatostatin was given intravenously to inhibit 
endogenous insulin secretion. Somatostatin has a short half life and therefore, a 
maintenance dose was given after each blood sample. Glucose was infused next making 
the pigs hyperglycemic which is necessary to avoid symptoms of severe hypoglycemia in 
response to the large insulin bolus subsequently administered. This bolus dose of insulin 
was given and the rate of glucose clearance from the plasma was determined with serial 
blood sampling. The test was successful in that all pigs followed a similar pattern of 
plasma glucose and insulin clearance. Also, somatostatin successfully inhibited 
endogenous insulin secretion, as shown by the unchanging C-peptide concentrations in 
response to glucose. Furthermore, none of the pigs exhibited any symptoms of 
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hypoglycemia. The rate of glucose clearance in our pigs was similar to that of the non-
diabetic control animals of Otis and colleagues (2003) indicating that the pigs were not 
insulin resistant. This novel adaptation of the traditional insulin sensitivity test was 
successful in our pigs. More studies using this novel technique are needed to determine 
the reproducibility of results. 
Table 4.11 summarizes the expected outcomes and observed outcomes. 
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Table 4.11: Summary of expected and observed results of fasting plasma analysis, oral 
glucose tolerance test, intravenous glucose tolerance test and insulin sensitivity test 
Expected Results Observed Results 
Fasting If an animal is diabetic Pigs did not exhibit hyperglycemia 
Plasma hyperglycemia and a high ratio of or hyperinsulinemia. 
Analysis glucose: insulin would be observed. 
Hyperinsulinemia and a low ratio of 
glucose: insulin indicates insulin 
resistance. 
Oral If an animal is glucose intolerant The OGTT was unsuccessful and 
Glucose they will exhibit a high glucose area yielded no reliable results. 
Tolerance under the curve and plasma glucose 
Test will not return to fasting levels. Area 
under the curve for glucose will be 
positively correlated to fasting 
glucose. 
Intravenous If an animal is glucose intolerant The animal's AUC, rate of glucose 
Glucose high glucose area under the curve clearance and time for glucose to 
Tolerance (AUC), slow glucose clearance and return to baseline were similar to 
Test inability for glucose to return to non-diabetic pigs. 
baseline would be observed. The There were no correlations between 
AUC and time to return of baseline fasting glucose and any outcomes 
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would be positively correlated to of the IVGTT when looking at all 
fasting glucose, whereas, the rate of pigs. In large littermates there was 
glucose clearance would be inversely a negative correlation between the 
correlated to fasting glucose rate of glucose clearance and 
fasting glucose. 
Insulin If an animal was insulin resistant The rate of glucose clearance was 
Sensitivity then the rate of glucose clearance similar to that of non-diabetic 
Test would be slow and negatively control animals used by Otis et al 
correlated to fasting glucose (2003). There was no correlation 
between the rate of glucose 
clearance and fasting glucose. 
Determining the effects of birth weight and postnatal growth rate on the 
development of type 2 diabetes 
In order to determine the effect of birth weight on glucose intolerance and insulin 
sensitivity, comparisons between runt and larger littermates were made. We expected 
runts to develop symptoms of diabetes more readily than their larger littermates, as 
observed in other models (Poore and Fowden 20042). However there were no differences 
in any measurements of glucose tolerance or insulin sensitivity between runts and larger 
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littermates at 8.5 months of age. Also, there were no significant correlations between 
birth weight and any measurement of type 2 diabetes. These findings differ from those of 
Poore and Fowden (20042) who found that lower birth weight pigs had significantly 
higher fasting glucose and insulin area under the curve during an intravenous glucose 
tolerance test than higher birth weight animals at 12 months of age. However, low birth 
weight rats have been shown to have better glucose tolerance in young adulthood (12 
weeks) compared to later in life (17 months). An age-dependent decline in glucose 
tolerance has been observed in humans (Preuss 1997), rats (Reavan et al 1983, Muzumdar 
et al2004) and pigs (Larsen, et al2001), irrespective of birth weight. Therefore, it is 
possible that the pigs in this study were too young to develop glucose intolerance or 
insulin sensitivity. In future studies, pigs should be tested for symptoms of diabetes in 
mid-to-late adulthood. 
Epidemiological studies out of Helsinki, Finland showed that low birth weight 
infants that experienced catch up growth had higher rates of type 2 diabetes than children 
that did not experience compensatory growth (Forsen, et al 2000). Their findings suggest 
that low birth weight combined with compensatory growth puts individuals at an even 
higher risk for developing chronic diseases in adulthood than low birth weight alone. As 
a result of those studies, we expected postnatal growth rate to be positively correlated to 
fasting glucose and insulin and glucose and insulin area under the curve. The rate of 
glucose clearance during the IVGTT and 1ST were expected to be negatively correlated to 
post natal growth. However, overall postnatal growth rate (g/d) during milk feeding in 
our pigs was not correlated to any measurement of glucose tolerance or insulin sensitivity. 
Again, these results differ from those of Poore and Fowden (2002), who found that 
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glucose AUC during an IVGTT was significantly positively correlated to growth rate 
from birth to one month. Since runt piglets were growing rapidly in abdominal 
circumference during milk feeding, correlations between abdominal growth rate and 
measurements of type 2 diabetes were also performed. Combining all pigs into the 
analysis, there were no significant correlations observed. However, within runts, the rate 
of glucose clearance was negatively correlated to abdominal circumference growth rate. 
Although this observation was expected, it was not enough evidence to suggest that 
postnatal abdominal growth rate significantly impacted later glucose tolerance. Since 
symptoms of glucose intolerance and insulin resistance were not related to birth weight or 
postnatal growth rate, the effects of current body weight, current abdominal 
circumference and current body mass index were determined. In humans, type 2 diabetes 
is strongly associated with obesity, particularly visceral obesity (Keller 2006). Therefore, 
we hypothesized a positive correlation between abdominal circumference and various 
measurements of type 2 diabetes. However, no significant relationships were found 
between any measurement of type 2 diabetes and current weight, abdominal 
circumference or body mass index. Presently, visceral fat is being measured and will be 
correlated with our measures of type 2 diabetes. 
Determining the impact of early postnatal nutrition and mode of feeding on the 
susceptibility to type 2 diabetes. 
The major goals of this study were to determine the effects of birth weight and 
postnatal growth rate on development of later chronic disease. Birth weight is primarily 
influenced by fetal nutrition, whereas, postnatal growth rate is affected by infant nutrition. 
Human studies have shown that infants that are breastfed grow more slowly than formula 
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fed infants (Dewey, 1998) and may be less likely to develop chronic diseases in 
adulthood. Therefore, we also wanted to determine the impact of early postnatal nutrition 
on the development of type 2 diabetes. In this study, the sow-fed group served as a 
breastfed control group. Where possible, sow-fed pigs were the same sex as their 
littermates and were closest in birth weight to the larger littermate. Therefore, the major 
difference between sow-fed pigs and large littermates was early postnatal nutrition and 
mode of feeding. If breastfeeding protects against later disease development, then sow-
fed controls should experience better glucose tolerance and insulin sensitivity than large 
littermates. However, in this study, there were no differences in any of the measurements 
of type 2 diabetes between sow-fed controls and formula-fed littermates. Therefore, 
infant nutrition did not impact glucose tolerance or insulin sensitivity at 8.5 months of 
age. Considering neither formula-fed group of pigs showed any signs of early 
development of insulin resistance and glucose intolerance, it is not surprising that the 
sow-fed group did not offer any additional protection. 
4.6. Summary 
Although the in vivo tests for diagnosing diabetes were successful, none of the 
pigs were found to be insulin resistant or type 2 diabetic at 8.5 months of age. There were 
no relationships found between indicators of insulin resistance or diabetes and birth 
weight or postnatal growth rate. 
Since the pigs were young adults it is not surprising that they did not develop 
overt diabetes. However, symptoms of insulin resistance and glucose intolerance were 
expected, with runts predicted to be worse than larger littermates and sow-fed controls 
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better than other animals. It is possible that conswning a healthy diet of standard pig 
chow protected the pigs from developing disease in early adulthood. Currently there are 
parallel groups of pigs consuming a high trans and saturated fat, high sugar and high salt 
diet. This poor diet may challenge the pigs to develop markers of disease earlier in life 
than when consuming chow. Desai and colleagues (2005) challenged male rats born from 
protein-restricted dams with a highly palatable high fat diet from weaning to young 
~~ -~----- - - ··· · - -~---~aoultnood ( 12 weeks). They found that low birth weight rats developed insulin 
resistance, but not high birth weight animals, irrespective of diet. Low birth weight rats 
fed the high fat diet had worse insulin resistance than low birth weight animals 
conswning the control diet. Male Gottingen miniature pigs fed a high fat, high sugar 
diets have been shown to develop obesity, and have increased fasting glucose compared 
to pigs fed regular chow (Larsen, 2001 ). Similar findings were observed in Ossabaw pigs 
fed a high fat diet (Dyson, et al2006). Feeding a poor diet to the pigs may allow for 
differences in glucose tolerance and insulin sensitivity to be observed between groups of 
animals. 
In this study, there may have been very subtle differences in insulin sensitivity 
between groups of pigs that went undetected because the IVGTT and IST were not 
sensitive enough. The gold standard for assessing insulin sensitivity is the 
hyperinsulinemic euglycemic clamp method (Cobelli et al 2007). In this method 
somatostatin is infused to inhibit endogenous insulin secretion, insulin is continuously 
infused to create hyperinsulinemia, and glucose is infused and frequently and rapidly 
measured in the blood in order to keep the individual in euglycemia. The rate of glucose 
infusion needed to maintain steady state is a direct measurement of whole body glucose 
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uptake, which describes the individual's insulin sensitivity. In practice this method is 
very expensive, time consuming and requires trained individuals to complete safely and 
effectively. The clamp method is not used routinely in clinical practice and is used only 
in specialized research trials where steady state conditions are required. Therefore, it was 
not employed in this study, but should be considered in future studies to determine subtle 
differences in insulin sensitivity between groups of animals. 
Bellinger and colleagues (2006) recently published an extensive review of all 
swine models of type 2 diabetes and insulin resistance. There are several breeds of pigs 
which have been used as models of diabetes including: Yucatan miniature pigs, Sinclair 
miniature pigs, Gottingen miniature pigs, Chinese Guizhow miniature pigs, Yorkshire 
(and Yorkshire crosses) and Ossabaw pigs. The Gottingen miniature pig is the most 
extensively used pig model for diabetes. The plasma glucose, insulin and lipoprotein 
concentrations have been well characterized. These pigs have primarily had chemically 
induced diabetes, but have also been shown to become type 2 diabetic in response to high 
fat feeding. The Ossabaw breed is found on the Ossabaw islands offthe coast of Georgia. 
They have been living in genetic isolation for centuries and are considered obese animals. 
A recent study by Dyson and colleagues found that Ossabaw pigs fed a high fat diet had 
higher triglycerides, and blood pressure compared to pigs fed a low calorie diet. The 
Ossabaw pig model is in its infancy but it may prove to be a model for fetal programming 
in the future. The Yucatan pig has primarily been a type 1 diabetes model, but has also 
been shown to develop impaired insulin sensitivity in response to overfeeding. Until 
now, no studies have used Yucatans as a model for fetal programming. 
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Bellinger and colleagues (2006) recently formulated a step-wise reference guide to 
validate the pig as a model for studying type 2 diabetes (Table 2 of Bellinger et al. 2006). 
Using this reference guide, we have only begun to validate our Yucatan miniature pig 
model of diabetes and fetal programming. There are several measurements that still need 
to be performed on our animals in order to more clearly determine their glycemic status. 
1. The major focus of this chapter has been defining Step 1. Fasting insulin, glucose 
and insulin sensitivity were measured using fasting plasma analysis, and in vivo 
tests of glucose tolerance and insulin sensitivity. 
2. The next step will be to determine the lipid profile throughout the study. Plasma 
cholesterol and triglycerides will be determined. This step is important, as the 
majority of diabetic individuals suffer some form of dyslipidemia. The previous 
chapter on compensatory growth discussed the body fat measurements made 
throughout the study. In the future, proximate analysis will be completed to 
determine the percentage fat in viscera and whole body. These percentages will 
then be correlated to measurements of type 2 diabetes making stronger 
comparisons than with abdominal circumference. 
3. The metabolic mechanisms and progression of diabetes is not completely 
understood. Many serum markers are thought to be related to diabetes including: 
C-reactive protein, leptin, TNFa, and resistan. Homocysteine is another serum 
marker that we did measure, but more markers should be measured in the future. 
4. Diabetic individuals are often hypertensive. We have measured mean arterial 
pressure by radio-telemetry. These data should be correlated to plasma insulin to 
see if there is a positive relationship. 
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5. End-organ damage often observed in animal models of diabetes includes: 
reduction in beta cell mass, atherosclerosis and endothelial dysfunction. 
Pancreatic beta cell mass is typically reduced in type 2 diabetes which limits the 
capacity for insulin secretion. In the protein-restricted rat model, low birth weight 
pups are born with a reduction in beta cell number (Bertin et al 1999). This 
reduction is thought to be a direct consequence of poor fetal nutrition which 
----~·-·--~--------- ·- ...... -· ... ··- - -~---· ----- -- (depending on infant nutrition) permanently alters beta cell function leading to 
glucose intolerance in later life. Beta cell mass will be measured by histological 
examination of the pancreas and total pancreatic insulin in our pigs. The aortic 
arch and the coronary artery will be examined for evidence of atherosclerosis. 
Endothelial dysfunction is also being measured. 
6. The final step in the reference guide refers to future studies examining the 
reduction of the above mentioned criteria when treated animals are compared to 
controls. 
It is obvious that validating an animal model of disease takes considerable time, 
effort and resources. This chapter is the initial step in identifying the Yucatan miniature 
pig as a model for type 2 diabetes and fetal programming. Completing the remaining 
analyses will help determine the impact of birth weight and postnatal growth rate on 
glucose tolerance and insulin sensitivity. 
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Chapter 5.0 Conclusions 
The overall goal of this research was to determine the effects of birth weight, 
postnatal growth rate and early postnatal nutrition on the development of type 2 diabetes 
in Yucatan miniature swine. In order to do so, we needed to demonstrate compensatory 
growth and validate the miniature pig as a model for type 2 diabetes. 
Runt piglets experienced a period of increased nutrient efficiency during the 
second week of milk feeding, characteristic of compensatory growth. Although, the 
composition of growth is yet to be determined, runt piglets appeared to be depositing fat 
towards the end of milk feeding based on abdominal circumference measurements. Runts 
eventually caught up in body size to their littermates in early adulthood. It was not 
surprising the Yucatan miniature pig proved to be a successful model for studying 
compensatory growth, as the domestic pig is already a well-characterized and established 
model of compensatory growth in the field of animal science (Foxcroft et al., 2006, 
Mitchell 2007). 
In order to determine the relationship between postnatal growth and the 
development of type 2 diabetes, we needed to validate the Yucatan miniature pig as a 
model for type 2 diabetes. We expected pigs to develop markers of insulin resistance and 
diabetes, with runts presenting markers more readily and severe than their littermates. 
Fasting plasma analyses and in vivo tests of glucose tolerance and insulin sensitivity were 
successfully developed in this model, but the results did not indicate diabetes 
development in any of the pigs or differences between groups of pigs. When 
measurements of insulin resistance and diabetes were correlated to birth weight and 
postnatal growth rate, no relationships were found. 
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Although the results from this study did not reveal any relationship between birth 
weight, postnatal growth rate or early postnatal nutrition and markers of type 2 diabetes, 
the miniature pig should not be ruled out as a model for fetal programming. Additional 
analyses including plasma lipid analysis, and beta cell mass are currently being completed 
to more accurately understand their metabolism. Risk factors of other diseases, including 
hypertension and cardiovascular disease, are also being performed to determine if this 
miniature pig model is valid for other diseases suspected to be programmed in utero. A 
parallel group of pigs fed a high fat, high sugar, and high salt diet is also currently being 
studied. It is possible that this poor diet may challenge the miniature pig to develop 
markers of disease more readily. 
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